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ABSTRACT
Purification of Anthrax Toxin Protective Antigen
Component and Characterization of Its
Binding Interaction With
Bovine Kidney Cells
by
Daniel Dalton Martin, Doctor of Philosophy
Utah State University, 1986
Major Professor: Dr. Frederick Post
Department: Biology (Microbiology)
Protective antigen component of

~

anthracis toxin

was produced and purified to the >99% level.

Toxin was

purified from culture supernatant utilizing concentration
and liquid chromatography techniques.

Purity was deter-

mined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
The purified protective antigen retained biological
and antigenic activity as evidenced respectively by lethality in Fischer 344 rats when injected in combination
with lethal factor, and by positive results on the Ouchterlony double diffussion assay.
Radioiodinated protective antigen was used both in
the in vivo and the in vitro experiments.

xi
In vivo distribution of labelled protective antigen
was determined in Fischer 344 rats.

Assay of organ tissues

for labelled protective antigen aided in the decision to
use Maden-Darby bovine kidney cells for the cell cultures
in the protective antigen binding studies.
Protective antigen binding studies , all performed at
37°C, evaluated criteria for receptor existence.

Labelled

protective antigen was found to bind specifically and
reversibly to Maden-Darby bovine kidney cells.
proved to be saturable.

Receptors

Scatchard analysis showed a rela-

-9
tively high dissociation constant (K

=

17 X 10

D
compared to other toxins in similar studies.

M)

This indi-

cated moderately low affinity for protective antigen.
The receptor was also partial ly characterized.

It

was shown that cholera toxin subunit B blocked the binding
of labelled protective antigen to Maden-Darby bovine kidney cells and that the protective antigen receptor was
insensitive to trypsin treatment.
tions suggest

Both of these observa-

a ganglioside as the receptor for protec-

tive antigen.
(90 pages)

LITERATURE REVIEW AND INTRODUCTION
The pathological effects of most bacterial diseases
are related to toxic substances released from the bacterial cell, rather than to the effects of the organism
itself (Smith and Stoner, 1967).

Diseases such as

diphtheria, cholera, tetanus, and botulism illustrate this
statement.
Bacterial Toxins
Definition.

Toxins, or poisonous substances of

biological origin, are a very diverse group.

Consequently

it is difficult to arrive at an all-encompassing definition.

Bonventre (1970) attempted to define microbial

toxins more specifically, classifying toxins as high
molecular weight proteins which are antigenic.

This defi-

nition, however, excludes endotoxins which are lipopolysaccharides and many fungal toxins such as T-2 which are
of low molecular weight and presumably not antigenic.

In

general terms then, bacterial toxins can be defined as any
poisonous substance produced by a bacterium whether it be
excreted from the cell or released upon cell lysis.
History.

The discovery of bacterial toxins was an

outgrowth of early work by Pasteur and Koch in isolating
causative organisms of disease in the late 19th century.
In the years following, toxins were also demonstrated as
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the principle cause of symptoms for many diseases.

Pro-

phylactic immunization with toxoids (modified toxins)
proved effective in some cases for disease prevention.

By

the early 20th century, scientific research on bacterial
toxins was well und erway (Stephen and Pietrowski, 1983).
The pathological effects of several bacterial diseases
were shown to be a direct result of toxin production (i.e.
diphtheria, botulism, anthrax, tetanus, cholera,
shigella, and plague).

The study of bacterial toxins

continued to be a focus of research.

Understanding of

pathogenesis, cellu lar function, and ligand-receptor interaction as well as vaccine development are some of the
benefits derived from toxin research.
Classification .

There exists a variety of toxin

classification schemes based on location of the toxin with
regard to the bacterial cell, chemical structure, biological effect of toxin, and number and interaction of components (Bonventre, 1970).
The terms endotoxin and exotoxin (i.e. inside the
cell or in the culture medium), which refer to the location of the toxin with respect to the organism which
produces it, have found wide usage in 'toxinology'.
Bonventre (1970) suggests, however, that these terms are
outdated since exotoxins, once thought to be metabolites,
can be found within the organism in young cultures
(Bonventre and Kempe, 1960).

Endotoxin of a gram -negative

organism can also be found extracellularly in amounts

greater than could b e accounted for by autolysis
(Crutchley et al., 1968).
The chemical composition of toxins is varied.

Toxins

may be lipopolysaccharides as in Yersinia pestis, the
organism responsible for plague (Hartley et al., 1974).
Many toxins are proteins, peptides or lipoproteins as are
those associated with Clostridium botulinum, Corynebacterium diphtheriae, Vibrio c holerae, Escherichia coli,
Bacillus anthracis, and Pseudomonas aeruginosa (Van
Heyningen, 1970; Gill, 1978).
The effect(s), and more particularly the site and
mode of action as a system of classification, provides
valuable information as well as a precise means of identifying a given toxin.

Unfortunately, the effect(s) and/or

site of action for many toxins is not known, which precludes this method of classification for general use.
For the purpose of this review, the "components" classification is useful.

There are three classes in this scheme:

simple, mixed, and complex (Bonventre, 1970).

Simple

toxins are those which exist as monomers, dimers, or
polymers of a monomeric subunit.
tive.

Their effects are addi-

The molecule can be active or may require modifica-

tion by cleavage or chemical/physical modification before
becoming active (Bonventre, 1970).

Mixed and complex

toxins, according to Bonventre (1970) are not readily
distinguished from each other but both require more than
one component of different molecular make up in order to
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become an active toxin.

Mixed toxins are composed of more

than one component which are chemically distinct and do
not form chemical bonds.
are inactive alone.

The components of a mixed toxin

Bacillus anthracis produces a mixed

toxin (Lincoln and Fish, 1970).

Complex toxins are also

composed of more than one component, but the components
are chemically bound together.

Some complex toxins are

defined as subunit toxins that can be separated into
~

functionally distinct subunits.

cholerae toxin (DeWolf

et al., 1981) and Clostridium tetani toxin (Morris et al.,
1980) for example have been demonstrated to have at least
two subunits.
diphtheriae,

Other examples of subunit toxins are C.
~

aeruginosa,

~

coli, and C. botulinum

toxins (Stephen and Pietrowski, 1983).
Biological effects of toxins.

The modes of actions

of bacterial toxins have been the subject of much research
since the turn of the century.

The advent of cell culture

allowed research into the action of toxins at a cellular
level.

Toxins require interaction with the cell membrane

to produce an effect.

Middlebrook and Dorland (1984)

suggested that toxins be classified as either membrane
damaging or intracellular acting.

Toxins may damage mem-

branes by modifying phospholipids, increasing membrane
permeability, sequestering cholesterol, or acting in a
detergent-like manner.
to damage cell membranes

Other unknown mechanisms may exist
(Stephen and Pietrowski, 1983;

Alouf, 1977; Craig et al., 1981).

Membrane damaging
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toxins include phospholipases (e.g.

~

perfringens,

toxins) , hemolysins such as those produced by gramnegative bacteria, and other lysins such as some of the
toxins of staphylococcal and streptococcal origins (Freer
and Arbuthnott, 1976).

Clostridium perfringens alpha

toxin was the first toxin for which an enzymatic mode of
action was shown.

In 1941 MacFarlane and Knight, as

reported by Stephen and Pietrowski (1983), demonstrated
that this alpha toxin was a phospholipase which cleaves
and releases phosphorylcholine from phosphatidyl choline.
In some cases, cell membrane damage was associated with
receptor binding of the toxin to the membrane.

Research

with staphylococcal leukocidin by Woodin (1970) and Noda
et al.

(1982) has shown that this toxin component binds

with the

GM1 ganglioside.

Apparently, without pene-

trating into the cell it exerts its effect of increasing potassium permeability and increasing prostaglandin
production and release.

Bhakdi et al . (1984) demonstrated

a correlation between toxin binding (perhaps associated with
channel formation) and the hemolytic membrane damage of
staphylococca l a l pha toxin.

Intracellular-acting toxins

seem to have a common mechanism of action involving:
1)toxin binding to ce l l membranes; 2)interna l ization or
trans l ocation across that membrane; and 3) interaction with
an intracel l ular target (Middlebrook and Dorland 1984) .
Toxin binding to cell membranes suggests the presence
of a receptor.

In some cases a specific toxin receptor
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has been identified.

Gangliosides are a group of cell

surface complex glycosphingolipids which serve as receptors for a number of toxins and endogenous mediators
(Osborne et al., 1982).

VanHeyningen (1983) stated that

the normal physiological function of gangliosides has not
yet been clearly defined.

A number of studies (Van

Heyningen, 1983; Osborn et al., 1982;

Cuatrecasas, 1973;

Ganser et al., 1983) have shown that ganglioside GMl is
highly specific for cholera toxin. Other studies with
cholera toxin and GMl interaction have shown that the
number of binding sites varies from one cell type to
another: for example, sites vary from a few thousand in
erythrocyte cells (Gill and King, 1975) to more than two
million in some mucosal cells (Holmgren et al., 1975).
The degree of binding of the toxin per receptor _nevertheless seemed to remain constant (VanHeyningen, 1983).

It

appears that an initial toxin-GMl complex is necessary for
a second component of the cholera toxin to enter the cell
and exert its effect of activating adenylate cyclase
(Osborn et al., 1982; DeWolf et al., 1981).
Mechanisms for internalization of toxin across the
cell membrane has also been a subject of investigation.
Research with diphtheria toxin has demonstrated receptor
mediated endocytosis.

Donovan et al.

(1982) found that

diphtheria toxin binds to the cell lipid bilayer and forms
transmembrane channels.

Another study with diphtheria

toxin also suggested that it could destabilize the
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integrity of the endocytosed vesicle membrane resulting in
r e l ease of toxin into the cytop lasm (Hudson and Neville,
1985).

Phosphoinositide was found to act as the cell

membrane binding site for a co mponent of diphtheria toxin
(Donovan et al., 1982).

Insertion of one diphtheria toxin

fragment into the cell membrane facilitates the entry of
an enzymatic fragment of the toxin into the cytoplasm
(Collier, 1975 and Pappe nheimer, 1977).

The enzymatic

fragment alters and renders inactive the elongation
factor-2

(EF-2) involved in protein synthesis (Middlebrook

and Dorland, 1981; Moynihan and Pappenheimer, 1981).
Several peptides have been found to cross the cell membran e in order to elicit an effect , among which are:
toxins of

~

diphtheriae,

~

aeruginosa,

~

the

cholerae, and

E. coli; colicins; and the plant toxin abrin (Gill, 1978).
As already indicated, the intracellular action of
toxins seem to center around interference with protein
synthesis and/or activation of adenylate cyclase.
Diphtheria toxin has been one of the major toxins studied
with regard to interference of protein synthesis.

In 1975

Collier suggested that diphtheria toxicity was due to
inhibition of protein synthesis and proposed a sequence of
events including receptor-mediated endocytosis, release
into the cytosol, and inactivation of EF - 2 by fragment A
of the diphtheria toxin, which would in turn interrupt protein synthesis.

In 1977 Collier (1977) attributed inhibition

of protein synthesis to the P. aeruginosa toxin as well.

Research since 1975 has supported and elaborated upon
Collier 's model of action for diphtheria toxin (Gill,
1978; Moynihan and Pappenheimer, 1981; Clemens, 1984).
Activation of adenylate cyc la se has been attributed
most specifica lly to cholera toxin (Kabir et al., 1978;
Holmgren, 1978).

Gill and King

(1975)

reported that NAD

was required as a cofactor for this action.

Recent

research has demonstrated that cholera toxin acts by ADPribosylating a membrane protein that is a guanine
nucleotide-binding regulatory component of adenylate
cyclase (Kaslow et al., 1981; Middlebrook and Dorland,
1984) .
Contributing to the pathogenesis of toxins is the
fact that cells of the immune system are also affected,
thereby decreasing host resistance.

Pertussis toxin was

shown to inhibit chemotaxis in human polymorphonuclear
leukocytes (Lad et al., 1985; Goldman et al., 1985).
Anthrax toxin has been shown to decrease phagocytic activi ty (O'Brien et al., 1985).

Friedman and Kohn (1976) demon-

strated that cholera toxin inhibited interferon action.
Practical applications of toxin research.

The study

of toxins has proven very valuable for development of
immunization against and treatment of diseases caused by
toxin-producing organisms.

Today, with the study of toxin-

cel l interaction, new and valuable possibilities exist.
It has been pointed out by Middlebrook and Kohn (1981)
that the study of binding properties of toxins has and

will find important relevan c e in medical research in the
production of hybrid hormones and toxins.

Utilizing the

binding properties of a toxin and/or the physiological
effects of a toxin component opens up new avenues of
medical therapy for treatment of tumor cells and reversal
of certain pathologies.

The use of hybrid toxins for

"target-killing" of tumor cells has been the subject of
much research in recent years (Gilliland et al., 1980;
Krolick et al., 1980; Blythman et al., 1981; Olsnes, 1981;
Moolten et al., 1982; Colombatti, et al, 1983).
Bacillus anthracis: History
and Pathogenesis of Disease
Bacillus anthracis is a rod shaped, Gram-positive,
spore-forming, facultatively anaerobic bacterium (Buchanan
and Gibbons, 1974).

Although it is pathogenic for man,

~

anthracis is zoonotic causing disease primarily in sheep,
cattle, and other lower animals.

The organism was first

associated with the anthrax disease in animals as early as
1850, but was conclusively proven to be the source of the
lethal infection by Koch in 1877.

From his work with B.

anthracis, Koch formulated the postulates which confirm
the causal relationship between a microorganism and the
corresponding disease (Freeman, 1979).
It is extremely difficult to erradicate anthrax
because the causative organism is a spore - former infecting
lower animals.

The spore is

environmental conditions.

highly resistant to extreme

Spores have been isolated from
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the soil up to sixty years after a natural deposition
(Wilson and Russell, 1964).

This makes contaminated soil

a source of recurring infection in grazing cattle.

Con-

taminated bone meal incorporated into cattle feed has also
been demonstrated to be a potential source of infection
for cattle (Davies and Harvey, 1972).
As noted, B. anthracis is pathogenic for man and can
be transmitted to man from infected animals.
of entry have been observed:
ary, and 3) gastric.

Three routes

1) percutaneous, 2) pulmon-

The disease is not normally trans-

mitted from human to human.

Man is most commonly infected

by handling contaminated animal materials and contracting
a cutaneous infection.

Handling hides and brushes, for

example, from contaminated animals may be a means of
infecting humans via the skin (Kendall, 1959).

The infec-

tion results in a localized boil or abcess which, if
treated medically at this point, will not result in septicemia.

Although anthrax septicemia is a critical condi-

tion, it does not always result in death if treated
promptly (Tahernia and Hashemi, 1972; Nalin et al., 1977).
Infection via the respiratory route is the most serious of
the three natural routes of infection in man.

Its fre-

quency is relatively low compared to infection arising
from the cutaneous source.

Respiratory infection has been

demonstrated to have greater occurrence among persons who
sort contaminated sheep's wool, and thus, has come to be
known as "wool sorters' disease"

(Dalldorf et al., 1971).
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This infe c tion can rapidly proceed to a fatal toxemia.
Intestinal infection of humans is uncommon but can be
rapidly fatal

(Nalin et al., 1977). Spore-contaminated

meats are the likely source (Sirisanthana et al., 1984).
Depending on the strain,
be encapsulated.

~

anthracis may or may not

The capsular material of most bacteria

is composed of polysaccharide whereas that of B. anthracis
is made of the polypeptide D-glutamic acid (Record and
Wallis, 1956; Zwartouw and Smith, 1956).

The capsule

seems to enhance the virulence of the organism by acting
as an " aggressin"

(Zwartouw and Smith, 1956), which en-

ables the organism to resist phagocytosis by the host's
immune response.
Anthrax Toxin
As in many bacterial diseases, it appears that the
anthrax organism itself is not physically responsible for
the lethal effect of advanced infection .

A combination of

toxic substances released from the bacterial cells under
specific growth conditions (Smith and Stoner, 1967) is
responsible.

It is also believed that the anthrax toxin

adds to the virulence of the organism (Smith, 1958; Keppie
et al.,1963; and Klein et al., 1963).
In vitro production of anthrax toxin in prepared
media (Puziss and Wright, 1954; Wright et al., 1954;
Harris-Smith et al., 1958; and Ristroph and Ivins, 1983)
has allowed researchers to obtain sufficient quantities of
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crude toxin: to use in studies; to purify (Fish et al.,
1968 and Fish and Lincoln, 1967; Leppla, 1982); and to
analyze components of the toxin (Thorne, et al., 1960;
Wilkie and Ward, 1967; Leppla, 1982, 1984).
Anthrax toxin is a complex consisting of three components

(Smith and Stoner, 1967; Smith and Stanley, 1962;

Lincoln and Fish, 1970).

The holotoxin, or complete

toxin, is biologically active ca using death accompanied by
severe pulmonary edema upon injection into test animals
(Smith and Stoner,1967).

The Fisher 344 male rat is

particularly sensitive to the toxin (Beall et al., 1962;
Haines et al., 1965) and may succumb within 40-50 min
after injection of culture filtrates

(Haines et al., 1965).

The three toxin components are protecive antigen (PA),
lethal factor (LF), and edema factor

(EF).

The PA is so

named by virtue of the protective immune response which it
e li cits in the host when injected alone.

Thus PA has been

used as an immunizing agent (Belton and Strange, 1954).
The LF component is lethal when combined with PA.

The EF

component induces local edema at the site of subcutaneous
injection when in combination with PA.

The components

have been shown to be neither lethal nor edema-inducing
separate ly (Haines et al.,1965).

Because of this com-

p lexity, the mode of action of the holotoxin is more
difficult to define than that of a simple toxin.
Much of the work with anthrax toxin has been conducted at Fort Detrick at Fredrick, Maryland in the U.S.
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and in Porton, England.

Because the research in both

centers proceeded independently, the nomenclature for
referring to the toxin components is not consistent.
American terms: edema factor
(PA), and lethal factor

The

(EF), protective antigen

(LF) correspond respectively to

factors I, II, and III in the British literature.

The

three toxin components have a molecular weight of 89,000,
85,000 and 83,000 daltons, respectively (Leppla, 1984).
Although~

anthracis was shown to be toxigenic as early

as 1954 (Smith and Keppie, 1954), interaction of the three
components of the anthrax toxin and its mode of action
upon cells has remained mostly undefined.
Test animals infected with B. anthracis have shown
many physiological effects. As indicated by its pathogenesis, anthrax has cutaneous, pulmonary, and intestinal
effects.

Meningo-encephalitic involvement in human anthrax

(Tahernia and Hashemi, 1972) and kidney pathology has also
been noted (Nalin et al., 1977; Smith and Keppie, 1954).
Whether the effects are primary or secondary is unclear,
but toxin production in vivo is responsible for the effects
(Fish and Lincoln, 1968).
Mechanism of Action
of Anthrax Toxin
Most early work on the mechanism of action of anthrax
toxin involved whole animal in vivo studies. With the
advent and fine-tuning of cell and tissue culture techniques, the study of the effects of toxins at a cellular
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level has been made possibl e .

Spec ies susceptibility can

be more readily determined through use of tissue culture
(Solotorovsky and Johnso n, 1970; Dorland, 1982).

Much of

the current work with anthrax toxin has been influenced by
Leppla.

Leppla (1982, p. 3162 ) stated that no further

studies on the mechanism of action of anthrax toxin are
known to have been performed since 1967.
Study of the cellular inte raction of the anthrax
toxin components PA and EF by Leppla (1982 and 1984) has
demonstrated that the EF component is an adenylate cyclase
and in combination with PA results in a dramatic elevation
of intracellular cAMP in chi nese hamster ovary (CHO) and
baby hamster kidney (BHK) cells.

Elevation of cAMP is

also observed in polymorph onuc lear neutrophils (PMN's)
along with decreased phagocytic activity by the PMN
(O'Brien et al . , 1985).

Oddly, PA and EF in tandem were

shown by Wade et al. (1985) to enhance chemotaxis of PMN's.
It has been hypothesized by Molnar and Altenbern (1963)
and Leppla (1984) that PA binds to the cell's surface and
acts as a mediator to allow EF and LF to enter the cell
and express themselves in the cytoplasm.
Gross changes in cultured cells in response to the
toxin vary with cell line.

Leppla (1982) reported elonga-

tion in CHO cells in response to PA and EF.

Bonventre

(1965) reported no visible cytopathic effects in guinea
pig spleen, mouse embryo primary explant, and buccal carcinoma cells.
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Past research with othe r toxins has elucidated the
presence of toxin-binding receptors in cultured cells and
animal host tissue (Critchley et al., 1981; Boquet and
Duflot, 1981; Dreyfus and Robertson, 1984; Yavin and
Nathan, 1986).

It is therefore likely that receptors for

one or more components of the anthrax toxin also exist.
Techniques of Toxin Study
Toxin purification.

In order to clearly identify the

actions of any mixed or complex toxin it is essential to
separate and purify the individual toxin components.
Efforts to purify the PA, EF, and LF toxin components of
B. anathracis

began with Thorne et al.

(1960).

By util-

izing a fritted glass filter they separated the toxin into
two components.

One component remained adsorbed to the

filter while the PA component was contained in the filtrate.

The adsorbed component, referred to as "filter

factor", was eluted with alkaline buffers.

The two com-

ponents were shown to be toxic in combination, but not
separately.

Stanley and Smith (1961)

later demonstrated

that the filter factor described above was actually two
components, namely EF and LF, which they termed factors
and III, respectively.

Much of the early efforts to

purify the components of anthrax toxin (see Lincoln and
Fish, 1970 for review) failed to eliminate cross comtamination and based the levels of purity on serological and
biological assays alone.
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More recently Leppla (1982 & 1984) used ammonium
sulfate precipitation and liquid chromatography methods to
purify all three anthrax toxin components.

The components

described in Leppla's work (1982), however, were only 80%
pure for EF and LF, and 90% or greater for PA.

Leppla

acknowledges, for instance, that the term "EF must be
viewed as describing a functional and not a physical
entity"

(Leppla, 1982, p.3163), indicating that the level

of purity allows some question as to the conclusions drawn
from experimental results using those components.
One of the most promising methods to accomplish purification is the use of highly specific monoclonal antibodies coupled in affinity chromatography (Machuga et al.,
1986).

Initial purification procedures rely on other

liquid chromatography techniques such as ion exchange
and gel filtration.

Still another method for producing

pure toxin component has been attempted.

Vodkin and

Leppla (1983) successfully cloned the PA gene in
and induced production of the PA component.

~

coli

Purification

by this method, however, has not yet yielded PA at greater
levels of purity than those previously reported.
Evaluation of toxin-cell interaction.

As noted, the

study of the effects of microbial toxins at a cellular
level has been advanced by improving cell and tissue
culture techniques.

Recently, these techniques have

allowed extensive study of the interaction of various
toxins with cell membranes (Noda et al., 1981; Osborne
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et al., 1982; Moynihan and Pappenheimer, 1981; Lin and
Taniuchi, 1980; Donta et al., 1982).

Studies with v.

cholerae toxin and E. coli enterotoxin (Donta et al.,
1982),

~

tetani toxin (Lietzk e and Unsicker, 1983;

Critchley et al., 1985), and C. diphtheriae toxin (Mekada
et al., 1982; Dorland, 1982) have been enhanced by the use
of ce ll culture.

Membran e preparatio ns of animal tissues

have also se rved to id entify receptor sites for toxins.
For example, tetanus toxin was found to bind to brain ce ll
membranes (Rogers and Snyder, 1981) and cholera toxin
bound to microvillus membran es (Bresson et al., 1984).
Once a given toxin was determined to be bound to a
given ce ll type, a specific receptor could be searched
for.

It i s now well estab li shed that cholera toxin is

bound by the GM1 ganglio side (Critchley et al.,1982;
Ledeen and Mellanby, 1977; Fishman et al., 1984).

It has

been shown that C. botulinum toxin also associates with
gangliosides (Kitamura et al., 1980) and that diphtheria
toxin binds to certain phospholipids in liposomes (Alving
et al., 1980; Donovan et al., 1982).

It has been recognized

through such studies that diff e rent toxins may bind to the
same or similar receptors (Tsuji et al., 1985; Simpson,
1984).

Toxin processing by ce ll s has also been elucidated

by cell culture studies such as t hose done with diphtheria
tox in (Dorland et al., 1979; Middlebrook et al . , 1978) .
Receptors have been solubilized and removed from cell
membranes and successfully purified, as with the rat
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intestinal receptors for

~

co li heat-stable toxin

(Dreyfus and Robertson, 1984).

Identification and subse-

quent isolation and purifi cation of receptors for bacterial toxins has allowed more detailed analysis of how
the toxin interacts with cells to exert their effects.
Diphtheria toxin has been o ne of the most intensively
studied in this regard (Donovan e t al., 1982; Zalman and
Wisni es ki, 1984; Kagan and Finkelstein, 1979; Hudson and
Neville, 1985). Diphtheria toxin acts intracellularly
which requires that the active portion of the toxin gain
entry into the cell.
toxin

In order to gain entry, diphtheria

interacts with the cell membrane by insertion of

one toxin fragment into the cell membrane facilitating the
entry of an enzymatic fragment of the toxin into the
cytoplasm (Collier, 1975; Pappenheimer, 1977).

Studies

with diphtheria toxin receptor interactions also have
demonstrated that different cell lines, as well as different species, seem to vary in the number of surface
receptors for the toxin (Middlebrook et al., 1978).

It is

therefore evident that identification and characterization
of a toxin receptor is helpful in elucidating the interaction of a toxin with a cell.
Research in the area of bacterial toxin receptors
seems to be of great comtemporary interest (for a review
see Eidels et al., 1983).

One of the most utilized

methods for detecting cell receptors for a given ligand is
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to radiolabel the ligand with
radioactivity.

and assay for gamma

This meth od has been used successfully for

toxins, hormones, and other biological ligands such as
ricin, a plant toxin (Ni colson et al., 1978), interferon
(Aguet et al., 1982; Aguet and Blanchard, 1981), thrombin
(Stein and Hoak, 1981), insulin (Katzen et al., 1981),
tetanus toxin (Morris et al., 1980; Critchley et al.,
1985; Rogers and Snyder, 1981; Lazarovici and Yavin,
1985), diphtheria toxin (Mekada et al., 1982), cholera
toxin (Nielsen et al., 1984; Fishman, 1980; Bresson et
al., 1984 ) , botulinum toxin (Kitamra et al., 1980), and
Staphlococcal leukocidin (Noda e t al., 1981).

Visualiza-

tion of receptor activity or binding location has also
been accomplished by utilizing ferritin (an electron dense
protein) or colloidal gold.

Th e gold may be either bound

to the lectin (Loftus and Albrecht, 1983; Gershon et al.,
1981) or conjugated to antibodies against the lectin.
These conjugates are then visualized by electron microscopy for a qualitative assay.

Immunofluorescence has

also been useful (Lietzke and Unsicker, 1983).
All the above methods for detecting receptors on cell
surfaces or membranes are indirect.

These methods do,

however, provide valuable information regarding such
aspects of toxin-cell interactions as binding affinities,
constants, saturability, reversibility, location of surface receptors, and receptor number per cell.
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Initial Determination
of Receptor Existence
Receptor research has advanced with the discovery of
not only toxins but also a wide variety of endogenous
substances such as hormones, growth factors, interleukins,
etc. all of which mediate their effects in the body
through some form of receptor.
Binding of a given molecular species to a surface is
not necessarily due to a specific receptor.

Nonspecific

binding can account for what may seem to be specific
binding (Cuatrecasas and Hollenberg, 1975).
Cuatrecasas (1974) proposed specific criteria in
order for the binding of a labelled ligand to be attributed to interaction with a receptor.
criteria are:

Among the necessary

chemical specificity, saturability, high

affinity, and reversibility.
Chemical specificity means that the ligand is bound
by a receptor which chemically and/or physically distinguishes the ligand.

Middlebrook et al.

(1978) noted that

unlabelled diphtheria toxin competes for receptor sites
with the labelled toxin as does cross reactive mutant - 195
(a toxin homlogue) and subunit "B" of the diphtheria
toxin.

This data, coupled with the observation that P.

aeruginosa "exotoxin" A and abrin did not compete for the
receptor, indicated that Middlebrook et al.
strated the specificity of the receptor.

(1978) demon-
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Saturability of t h e re cepto r sites by a specific
ligand can be demonstrated eit her by treating the receptor
sites with increasing concentrations of the ligand over a
specific time period or by treating the receptor sites
with a set concentration of ligand over a variable period
of time.

At some point all the specific receptor sites

will be occupied, thus achieving saturation and demonstrating a limited number of receptor sites.
Affinity can be demonstrated by calculation of an
association constant.

Scatchard (1949) analysis allows

determination of an association constant for the receptorligand complex. Great or high affinity is evidence that
the ligand is capable of maintaining association with the
receptor of a cell, for example, for a period of time
sufficiently long enough to elicit the intended response.
Reversibility can be shown if bound labelled ligand
is removed by an excess of unlabelled ligand.

This response

indicates competition for the receptor site.
Binding Studies of
Anthrax Toxin Components
The study of toxin binding kinetics looks at the
quantitative and temporal features of toxin binding to
receptors.

The kinetics of the binding and interaction at

a cellular level of anthrax toxin components has not been
studied to the extent that other toxins have been studied.
Prior to 1980, the work with anthrax toxin was confined
mostly to in vivo experiments related to the study of how
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the toxin acts.

Gladstone (1946) used the protein-

containing anthrax culture supernata nt to invoke a protective immune response in animals.

Smith and Keppie

(1954) induced edema and lethality in test animals with
injections of sterile plasma from guinea pigs infected
with anthrax.

With the subsequent identification of three

distinct components of the anthrax toxin (Stanley and
Smith, 1963), work was then directed toward purification
of each component and determination of how each component
functioned.
In early work it was shown that EF and LF appeared to
compete for the available PA after intravenous injection
into test animals (Stanley and Smith, 1961).

Leppla

(1982) demonstrated that EF acts as an adenylate cyclase
to elevate cyclic AMP in cultured cells only in the
presence of PA.

Working with the toxin components with

cultured cells, Leppla (1982) also demonstrated that LF
blocks the action of EF on CHO cells, BHK-21 cells, and
fetal Rhesus Lung (FRhL-2) cells, presumably by competing
for the PA at the cell surface.
The apparent function of PA as a mediator for the
passage of other biologically active component(&) is similar to the "A"/"B" subunit scheme for other bacterial
toxins such as in diphtheria and cholera.

In these cases,

however, the subunits are covalently connected, whereas the
anthrax toxin components

are thought to be physically
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independent of each oth e r

(Le ppla, 1984).

This aspect of

the anthrax toxin has facilitated the separation/purification of the components.
An interesting aspect of Leppla's work (1982)

from

the standpoi nt of receptors is that the peak response of

CHO cells to EF occurred at concentrations where EF and PA
were both the same (about 1 ug/ml). This is consistent
with a binding role for PA.

Leppla (1982) also noted that

th e data indicated that the "essential components of the
uptake system for EF are not consumed during EF action "
(p. 3165).

This observation implies that PA is not rapidly

internalized and remains bound at the cell surface, at
least in CHO cells , ready to mediate the binding or passage of EF or LF.
The available information points to the existence of
receptors for PA on susceptible cells.

Receptors have

been identified for certain toxins such as the GM1 ganglioside for cholera and heat-labile toxins.

I t is

possible , therefore, that PA binds to a similar receptor.
With regard to characterizing the binding of PA, or any
other of the anthrax toxin components, to cultured cells
or tissue samples there is, to the author's knowledge, no
published work.

Any research attempting to characterize

the binding of PA to cultured cells requires the PA to
approach levels of purity beyond that reported in the
literature thus far.
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Research Proposal
I t was the aim of this research to purify the ant hra x
toxin protective antigen (PA) component and to character ize its binding to a se l ected ce ll line, namely Mad e nDarby bovine kidney (MDBK) cells.

To accomplish this the

subsequent outl ine was followed:
1)

A toxigenic strain of Baci llu s anthracis was

cultured in vitro.
-- ----2)

Biologically active holotoxin toxin was produced

and identified.
3)

The Protective Antigen (PA) component was

purified to l eve ls > 99%.
125

4)

The PA was labelled with

for use in a

radio binding assay.
5)

Distribution and localization of the labelled PA

in vivo was determined after injection into a susceptible
host.
6)

A binding assay with the labelled PA in an

in vitro ce ll culture system was developed.
7)

The criteria for a receptor as outlined by

Cuatrecasas (1974) was investigated on a selected cultured
ce ll type .
8)

It was determined if the receptor for the

PA is proteinaceous by treatment with trypsin.
9)

It was determined if the binding unit of

cho ler a toxin could block the binding of PA, thus indieating the possibility of a ganglioside receptor.

25

MATERIALS AND METHODS
Toxin Production
Bacillus anthracis (Vollum 1B initially then, Sterne
strain) vegetative cells were streaked on blood agar for
isolation.

Isolated colonies were transferred with a

sterile inoculating loop to another blood agar plate and
incubated at 37°C for 15-18 hr.

The second plate was

flooded with a sterile growth medium composed of Casamino
Acids (Detroit, MI . ) with chemical supplements as described by Haines et al.
growth medium.

(1965), hereafter referred to as

The surface growth was suspended in liquid

medium and then placed in a sterile tube for mixing.
Aliquots were dispensed and frozen for subsequent use as
inocula.
A blood agar plate was heavily streaked with cells
from a thawed inoculum aliquot and incubated for 18 hr at
37°C.

The plate was flooded with sterile growth medium

and the colonies suspended and mixed to a uniform suspension.

A sufficient volume of this mixture was transferred

to about 15 ml sterile growth medium to give a reading of
between 18-26 units on a Klett spectrophotometer.

A 0.5 ml

portion of this suspension was transferred to a Fernbach
flask containing 460 ml growth medium and 5 ml sterile, 20%
aqueous, glucose solution and was incubated at 37°C.

After

26
4 hr incubation, 50 ml of sterile 9% sodium bicarbonate
solution was added and the flask was returned to 37°C for
an additional 18-20 h.

After the complete incubation

cycle the bacteria were pelleted by centrifugation at
10,000 x G

for 30 min in sterile centrifuge bottles.

Subsequently, sterile polyethyleneglycol 6,000 (PEG)
(Union Carbide Corp.,

s.

Charleston, W.VA.) was added

directly to the supernatant to yield 0.01% PEG. The PEGsupernatant was subsequently filtered through a prefilter
and a 0.22

pm

membrane filter

(Millipore, Bedford, MA.).

Positive pressure was maintained with prepurified nitrogen.

The sterile filtrate was collected in sterile flasks.

This filtrate constituted the crude anthrax toxin.

One ml

of the sterile supernatant was plated on agar plates to
check for contamination.
The crude toxin was routinely tested for antigenic
activity by the Ouchterlony double diffusion method
(Ouchterlony, 1948) and for biological activity

by I.V.

injection into Fisher 344 male rats (Haines et al., 1965)
weighing between 225 and 300 g.

Assay of EF was accom-

plished by subcutaneous injection into shaved backs of
rabbits and visual observation for edema on the following
day. The goat antisera to PA, LF, and whole cell B.
anthracis used in the Ouchterlony assay were gifts from
Dr. Stephen Leppla (United States Army Medical Research
Institute of Infectious Disease, Ft. Detrick, MD.).

The

antisera against PA and LF, which contained hemolyzed red
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blood cells were further "purified" by liquid chromategraphy with Affigel-Blue (BIO-RAD, Richmond, CA.).
The crude toxin was stored at -20°C or was put
through additional concentration steps.
Toxin Concentration
Approximately 2 L of crude toxin were filtered overnight through a YM 10 or PM 30 Amicon filter

(Danvers,

MA.), with a 10,000 or 30,000 molecular weight exclusion
limit respectively, utilizing a nitrogen gas positive
pressure dialysis cell and holding tank.
was about 50 ml.
trated toxin.
crude toxin.

The final volume

This solution constituted the concen-

This was assayed in the same manner as the
The concentrated toxin was subsequently

stored at -20°C until dialysis prior to additional purification.
Protective Antigen Purification
The concentrated toxin was thawed and dialyzed overnight in 0.002 M KH PO , 2 mM 2-mercaptoethanol (2-ME),
2

4

and 0.05 M NaCl buffer pH 7.1 at about 4°C.
upon the viscosity of the

Depending

dialyzed toxin (the more con-

centrated, the more viscous) the toxin was diluted so as
to facilitate passage through the chromatography column.
Routinely, approximately 40-50 ml of toxin solution was
loaded onto a column of hydroxylapatite (Bio-Gel HTP, BIORAD, Richmond, CA.).

The column was 2.5 em in diameter,

about 10 em high, and used about 75 em

hydrostatic
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pressure to give 0.1 ml /c m / min.

After the toxin was

loaded, the column was wa s hed with starting buffer (2 mM
KH PO
2

pH 7.1) with 2-3 column bed volumes.

The eluent

4

was monitored by spectrophotometry (254 nm), and when the
absorbance returned to the baseline the elution gradient
was started.
The toxin components were eluted from the HTP column
with a buffer gradient of 0.002 M to 0.4 M KH PO
2

at pH
4

7.1, containing 2 mM 2-ME and 0.05 M NaCl in 500 ml total
volume.

The gradient was developed with a GM-1 gradient

maker (Pharmacia, Uppsala, Sweden), and ran at the same
flow rate as above or approximately 0.5 ml/min.
fractions,

The PA

identified by Ouchterlony double diffusion

immunoassay and electrophoresis were dialyzed overnight in
0.01 M Tris (hydroxymethyl) aminomethane (Tris) with 2 mM
ethylene diamine tetracetate (EDTA) and 2 mM 2-ME, pH 8.1
(ion exchange chromatography starting buffer). These dialyzed fractions were then loaded onto an equilibrated DEAE
(Cellex D, BIO-RAD, Richmond, CA.) column (1.4 em in
diameter and 6 em high) washed with starting buffer with
several void volume equivalents.

The bound material was

then eluted with a 0.0-0.3 M NaCl gradient, 500 ml total
volume in starting buffer.
Electrophoresis of chromatography column fractions.
Analysis of fractions from the HTP and DEAE columns was
performed in the following manner.

A sample from each
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fraction was electrophoresed using sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) according
to the technique of Laemmli (1970).

After electrophoresis

at 6 watts (constant power mode) , the gel was stained with
coomassie blue (R-250) for 1 hr and then destained overnight by diffusion in 40% methanol and 10% acetic acid.
Silver staining (BIO-RAD) as well as coomassie blue
staining was employed.
Determination of purity.

A gel with a PA band to be

assayed for purity was soaked in 1% glycerol and 10%
acetic acid for 1 hr after destaining.

The gel was trans-

ferred to a clean glass plate and an absorbance scan was
performed on each lane of interest on a DU-8 Beckman
spectrophotometer.

The sensitivity was set at the highest

setting with a minimum peak value of 0.001.

The wave-

length was set at 561 nm and the speed was 2 em/min.
To determine antigenic purity, an aliquot of DEAE
column fractions, crude toxin, and concentrated toxin were
electrophoresed through agarose gel according to the
Grabar-William's technique (outlined by LKB, Bromma,
Sweden, application note 249) and then diffused against
antibodies to PA and antiserum to B. anthracis whole cell.
To determine if the minor bands present in the PA
fractions were breakdown products of the PA, the following
experiment was performed.

Protective antigen was run

parallel in two lanes of a 10% SDS-PAGE gel, 1.5 mm thickness.

After completion of the run, the gel was cut
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lengthwi se between the two lan e s and one side was stained
to determine the location of the PA band.

The correspond-

ing area was then cut out of the unstained half and mixed
with SDS-PAGE dissociati o n mix and allowed to stand at
room temperature for several days.

The unstained PA band

was then electrophoresed again and stained with coomassie
blue.
The pure PA fractions were pooled, dialyzed, lyophilized and stored at -20°C.
Biological Activity of Pure PA
Purified toxin was assayed in the same fashion as the
crude and concentrated toxin.

The lyophilized PA was

reconstituted with sterile triple distilled H 0 and tested
2

with aliquots of LF (as identified by Ouchterlony analysis
and SDS-PAGE) from the HTP fractions which showed no PA
activity.
Protective Antigen Labelling
Lyophilized PA was reconstituted with triple dis125
tilled H 0. The PA was labelled with
according to
2
TM
the Pierce (Richmond, CA.) procedure using Iodobeads
The Iodobeads consist of N-chloro-benzene-sulfonamide
(sodium salt) covalently bound to polystyrene beads. The
125
Iodobeads provide the oxidizing power to drive the
I
labelling of tyrosine · residues. Briefly, two Iodobeads
125
125
were "loaded" with
I in a 0.2 ml volume of
I solution (New England Nuclear, Boston, MA.) containing 200 pCi
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activit y for 10 min.

Th e bead s were transferred to

another reaction vial conta i n i ng 2.0 ml of PA in solution
at 160 pg/ml.

The pr o t e in so lution was allowed to react

for 10 min, then it was r e moved from the reaction vial and
12 5
held in an ice bath. Free
I was removed by gel filtraTM
tion in a G-100 Sephadex
(Pharmacia, Uppsala, Sweden)
c olumn.

All fractions we r e as sayed for gamma emission in

a Packard 5650 auto-gamma ma c hin e , with 80% efficiency, to
125
determine separation of free from bound
I. Concentration was adjusted to 30 ug / ml f o r PA.

Determination was

made using the BIO-RAD (Ri c hmo nd, CA.) protein assay kit.
Specific activity was 128,000 CPM/pg PA.

The labelled

protein (PA*) was stored at about 4°C for 40 hrs. until
use.
The labelling of PA f o r use in vivo resulted in lowlevel specific activity.

In order to obtain greater sen-

sitivity for use in cell c ulture work the following label125
I was obtained
ling technique was employed. One mCi of
from New England Nuclear (Boston, MA.).

Bolton-Hunter

reagent (with sulfo group) and Iodobeads were obtained
from Pierce Chemical Company (Rockford, IL.). Three Iodo125
beads were added to 1 mCi
I in 200 ul of 25 mM NaH PO
2

buffer pH 7.6 and allowed to "load" for 10-15 min.
Bolton-Hunter reagent (0.9

~g

allowed to label for 7-10 min.
approximately 20

in 9

~1)

was added and

Then 20-30

~g

of PA in

pl were added for an additional 50 min.

4
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All reactions were carried o ut at room temperature.

After

reaction time was complete, the reaction mixture was
placed on a G-50 Sephadex column, the Iodobeads rinsed
with 100-200 pl buffer and the rinse also placed on the
column.
NaH PO
2

The column was eluted with about 5-10 ml of 25mM
or 25 mM N-hydroxyethylpiperazine-N'-2-ethanesul-

4

fonic acid (HEPES) buffer.

The fractions were collected

and assayed for gamma emission.

The fractions which con-

tained the protein peak were pooled.
This labelling procedure was performed 8-10 times
during the course of the study.

The specific activity

ranged from about 1.0 to 1.5 pCi/pg PAusing the BoltonHunter reagent.

PA.

125
Determination of dissociation of ---I from labelled
125
To determine the degree of dissociation of the

over time from the labelled PA, the following experiment
was performed:

An aliquot of 0.1 ml of previously labelled
TM

PA was loaded onto an equilibrated G-50 fine Sephadex
column (2.5 ml in a 3.5 ml syringe barrel).

Equal-volume

fractions were collected during the filtration until
several column volumes of buffer had been collected.
fractions were then assayed for radioactivity.

The

Before

injection into test animals, the PA* solution was diluted
with sterile 0.01 M Tris to achieve desired concentrations
of PA*. Three amounts of PA* were used: 5 pg, 10 pg, and
20 pg.
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Cell Line Selection and Culture
Prior to injection, each of three rats was anesthetized with 1 ml of a 10% solution of urethane by injection
in the leg pouch on the inside of the thigh.

Injection of

the PA* with LF mixture was via the penile vein of the
Fisher 344 male rats.

All subjects were sacrificed within

a 15-20 min time period and upon opening the chest cavity
for dissection each was perfused to reduce the volume of
blood in the organs of interest.

As each organ was re-

moved, it was rinsed in a saline solution, weighed,
minced, and placed in a plastic tube for assay.

The

organs removed for assay were the brain, lungs, liver,
heart, spleen, and kidney.

Blood was also assayed from

the subjects which received doses of 10 pg and 20 pg of
PA*.

The thyroid tissue was assayed from the animal

which received 10 pg PA*.
Madin-Darby bovine kidney (MDBK) cells obtained from
the American Type Culture Collection (Rockville, MD.) were
2
grown as a monolayer to confluency in 75 em flasks in
Eagle's Minimal Essential Medium (MEM) with 25 mM HEPES
buffer, 10% fetal bovine serum (FBS), and penicillin/
streptomycin (50 units/ml and 50 pg/ml respectively) at 37°

c,

and 5%

co

When the cell sheets reached confluency
2
the cells were removed with trypsin and diluted 1:6 with

growth medium and "seeded" onto
(Costar, Cambridge, MA.).

24 or 96-well plates

They were then incubated for
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use the next day.

Dilution s of 1:12 were seeded onto

plates to be used 2 days after.
Estimation of
Cells per Well
The determination of the number of cel l s per confluent
monolayer in the tissue culture wells was done in the
following way.

The cell sheets in 3 wells were rinsed

with MEM and then treated with 100 pl of trypsin/EDTA at
0.15% and 0.1 respectivel y
plastic well.

to remove the cells from the

The cells from each well were transferred

to separate tubes and the wells were rinsed with 100 pl
MEM.

Each rinse was transferred to its respective tube.

Th e conte nts of each tube was thoroughly mixed and the
cell concentration was determined using a hemacytometer.
Protective Antigen
Binding Experiments
PA* binding assay.

The PA* was diluted to the

desired concentration in MEM, 25 mM HEPES with 10% FBS.
The controls had 100-fold excess of unlabelled PA.
Confluent MDBK cells in 24-well or 96-well plates
were rinsed twice with MEM without FBS or antibiotics,
then PA*

(with or without excess unlabelled PA)

to each well and allowed to bind .

For the 24-well plates

300 pl of treatment volume was used .
plates 50 pl was used.

was added

For the 96-well

After binding, the PA* solution

was suctioned off of the monolayer and the well was rinsed
4 times with MEM.

The monolayer was then treated with
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trypsin/EDTA at 0.15% and 0.1% respectively at 37°C and
the detached cells transferred to a plastic tube containing absorbent paper. Each well was then rinsed with 100 pl
MEM, 25 mM HEPES and the rinse placed into its corresponding tube and all tubes assayed for gamma emission.
Determination of optimum excess level of cold PA.

In

order to determine the level of unlabelled PA to use
during the binding experiments and to aid in determining
the degree of specificity of PA* for the receptor, the
following experiment was done.

Monolayers of MDBK ce ll s

in 24 well plates were rinsed and treated with PA* at 500
ng/ml with parallel wells run with 10, 25, 50, 100, and
500 fold excesses of unlabelled PA for 1 hr at 37°C.

The

cell sheets were rinsed, removed, and counted as described
above.
Effect of concentration of PA* on binding to MDBK
cells .

Monolayers of MDBK cells in 24-well or 96-well

plates were rinsed and treated with increasing concentrations of PA* with parallel wells containing a 100-fold
excess of unlabelled PA.

All wells were incubated for 1

or 10 hr at 37°C and then removed, rinsed, and assayed.
Assessment of binding of PA* to MDBK cel l s over time.
Monolayers of MDBK ce ll s in 96-well plates were rinsed and
treated with PA* in concentrations of 500 , 1000, 2500, and
3000 ng/ml with parallel wells containi ng a 100-fold
excess of unlabelled PA at 37°C.

At timed intervals, one

set of three wells for each concentration with its corre-
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sponding parallel control serie s was removed from incubation and assayed for activity of bound PA*.
Reversibility of PA* binding.

To determine if the

binding of PA is a reversible event, 3-well sets of MDBK
cells were treated for 6 hr with PA* at 2187 or 2500
ng/ml with corresponding controls.

One set was assayed

at this time and termed 100% binding at zero time.
treatment volume in the other
unlabelled PA at 2000 ng/ml.

The

sets were replaced with
The cell sheets were then

rinsed and assayed for bound activity at timed intervals.
Binding affinity of PA*.
action,

C~atrecasas

Utilizing the law of mass

and Hollenberg (1976) suggested the

following equation for determining the dissociation constant (K ) :

D
K

(H]

D
Where:

[R]

[HR]

H

hormone or ligand

R

receptor

HR

=

ligand-receptor complex

Another method for deriving the K was presented by
D
Scatchard (1949).
This is a graphic representation of the
data which plots the ratio of bound/free ligand on the
ordinate and the corresponding

amount of bound ligand on

the abscissa, producing a negative slope.

The slope of the

regression-fitted line is equal to -1/K • Westphal (1971)
D
favors this method for evaluating binding data of the type
presented in this research.

The Scatchard analysis deter-
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mines the maximum binding sites

(abscissa intercept) as

well as a visual representation of data that may suggest
information concerning number of different receptors.
The K

for PA* was compared to that of other toxins.

D
Partial Characterization
of the PA Receptor
Effect of trypsin treatment.

Confluent monolayers of

MDBK cells in 96-well plates were treated with 0.15%
trypsin plus 0.1% EDTA for 10, 15, and 20 seconds at 25°C.
The cells were then rinsed 3 times with MEM with 20% FBS
and incubated for 20 min.
scopically before use.

The cells were observed micro-

The monolayers were rinsed and

then treated with PA* at 3000 ng/ml. Untrypsinized cells
were simultaneously treated with the same PA* with controls. The monolayers were treated
then assayed for bound activity.

45 min, rinsed, and
All experiments were

performed at 37°C.
Blocking of PA* binding sites with cholera toxin subunit B.

Confluent monolayers of MDBK cells in 96-well

plates were treated with 0.0-, 0.1-, 1.0-, 10.0-, or 50.0fold excesses (on a molar basis) of cholera toxin subunit
B relative to final PA* concentration, for 105 min.

After

this time the PA* was added directly to the 50 pl cholera
treatment volume to achieve 2500 ng PA*/ml and allowed to
react for 2 additional hr.

The wells were then assayed.

All experiments were performed at 37°C.
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RESULTS
Toxin Production
and Assay
Biologically active culture supernatant (crude toxin)
was obtained by culturing the anthrax bacillus and the
crude toxin was concentrated.

A 1 ml intravenous injec-

tion of the crude toxin into Fischer 344 rats resulted in
lethality accompanied by severe pulmonary edema as evidenced by increased lung weight, compared to control animals, and fluid excretion from the nose.

Time of death in

test animals varied with each lot and ranged from about 60
to 90 min.

The crude toxin, which was concentrated approx-

imately 50-fold, also retained lethality when diluted back
to the crude toxin level.

Time to death of test animals

injected with diluted toxin concentrate ranged from about
65 to 124 min.

Table 1 gives an example of time to death

with one lot of crude and concentrated toxin produced with
the Vollum 1B strain.

Lethality of toxin produced with

the Sterne strain was essentially the same.

The Ouchter-

lony double diffusion assay of crude and concentrated
toxin showed lines of precipitation against anti-PA and
anti-LF.

Table 2 shows the Ouchterlony and edema assays

with the dilute concentrated toxin of the same lot.
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TABLE 1
TIME TO DEATH OF TEST ANIMALS
INJECTED WITH CRUDE OR CONCENTRATED TOXIN
Toxl.n
a
preparation

T1me to
death (min) b

Crude
(flasks 1-3)

67

Crude
(flasks 4-6)

78

Concentrate
diluted 1:50

124

a
Injection volume was 1 ml iv.
each weighing between 220-246 g.

One rat per preparation

b

Data is from one representative lot of toxin harvest
produced with B. anthracis Vellum 1B strain. Lethality
with toxin from-the Sterne strain was essentially the
same.
TABLE 2
OUCHTERLONY AND EDEMA
ASSAY OF DILUTED TOXIN CONCENTRATE
Assay

Dilution
of toxin

Ouchterlony
a
Anti-PA
a
Anti-LF
Edema test
------

Test result

1:64

+

1:64

+

1:32

+

1:64

a

PA

protective antigen.

LF

= lethal factor.

b

Data is from one representative lot of toxin
harvest from~ anthracis culture supernatant.

b
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Protective Antigen
Pur1.f1.cat1.on
Liquid chromatography.

Fractions eluted from the HTP

column as analyzed by SDS-PAGE revealed that PA which
eluted with a peak at 150 ml was well separated from the
bulk of the LF, which eluted with a peak at 210 ml (Fig.
1).

The spectrophotometric profile at 254 nm also shows

peaks at 90 and 130 ml.

The first peak

showed no protein

with coomassie blue and higher absorbance at 260 nm than
280.

The second peak (at 140 ml) proved to be a low

molecular weight contaminant in addition to some PA.

100

0

60

16

100

126
El.UENT (mi.)

160

116

200

226

Fig. 1. Separation of B. anthracis toxin components on
hydroxylapatite. Dialyzed, concentrated toxin was "loaded"
onto a column (2.5 em diameter and 10 em high) of hydroxylapatite, then washed with several void volume equivalents
of starting buffer. The column was eluted with a buffer
gradient of 0.002 to 0.4 M KH~P04 , 2 mM 2-mercaptoethanol,
and 0.05 M NaCl at pH 7.1 in a total volume of 500 ml.
The eluent was monitored by in-line spectrophotometry at
254 nm and collected in 2 ml fractions.
Protective
antigen eluted primarily in the peak at 150 ml. Lethal
factor eluted primarily in the smaller peak at 210 ml.
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Analysis of the pooled PA fractions eluted fr om th e
subsequent DEAE column revealed that the PA eluted first
at approximately 0.05 M NaCl.

Initial fractions were free

of contaminants with successive fractions containing two
lower molecular weight peptides as shown by coomassie blue
staining (Fig. 2).

Silver staining in concert with the

coomassie blue failed to reveal any additional contaminants of the PA fractions

34 35 36

:rr 00

(Fig. 3).

38 39 41 43 45 50_

1

M

-------L

Fig. 2. SDS-PAGE of purified protective antigen (PA)
stained with coomassie blue. Fractions eluted from DEAE
column show PA without contaminating bands in fractions
36 and 37. Subsequent fractions (38,39, etc.) show additional minor lower molecular weight bands later shown to
be breakdown products of PA. The 3 high molecular weight
markers (HMWM) represent 200 K, 116.3 K, and 92.05 K
daltons starting from the top.

42
PA 5().,1

PA 100..1

BSA

PA15()..1

Fig. 3. SDS-PAGE of purified protective antigen (PA)
stained with coomassie blue and si lver staining. Purified
PA, bovine serum albumin (BSA), and conce ntrated toxin
were electrophoresed and then stained with coomassie blue
and silver staining technique. Silver staining showed no
additional contaminating bands in the PA samples.

Determination of purity.

The scanning gel densi-

tometry performed on the PA sample after the purification
sequence showed only the PA band registering an absorbance
(Fig. 4).

With the sensitivity at the highest (most

sensitive) setting and the minimum absorbance set at
0.001, the PA peak accounted for 100% of detectable bands.
However, it was possible to detect with the eye two very
faint lower molecular weight bands in the same lane with
the PA. Taking this into account, the purity level of the
PA was determined to be > 99%.

43

0.4

~

0.15

Cl)

.Q

~

0

-0.1
75

125 145
mmOFGEL

Fig. 4. Densitometric scan of purified PA preparation
(approx. 8 ~g protein) on SDS-PAGE stained with coomassie
blue. An SDS-PAGE gel was mounted on a clean glass plate
and was kept moist with 1% glycerol/10% acetic acid mix.
The gel was then scanned at 561 nm in a Beckman DU-8
spectrophotometer to obtain the absorbance profile shown.
The sensitivity was set at 1 (greatest sensitivity) with a
minimum peak value setting of 0.001. The data obtained
indicated that the PA peak (at about 135 mm) accounted for
100% of the protein in the purified PA preparation. Two
very faint bands, however, were visible but failed to be
detected at the 0.001 absorbance setting. Taking this
into account, the purity level of the PA was determined to
be > 99%.
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Grabar-William's immunoelectrophoresis of purified PA
showed only one immunoreactive band against both anti-PA
and anti-B. anth ra cis antisera (Fig. 4).

Fig. 5. Grabar-Williams' immunoelectrophoresic analysis
of B . anthracis toxin and protective antigen (PA) .
Purifie~PA was loaded into the center wel l (3), crude toxin
into we ll s 1 & 4, and concentrated toxin into wells 2 & 5 .
After electrophoresis , anti-PA was l oaded into channels 1
& 3 and anti-spore antiserum was loaded into channels 2 &
4 . PA shows only one immunoreactive band against both
antisera, whereas both the crude and concentrated toxin
showed 2 antigenic species against the anti B. anthracis
antiserum.
-Demonstration of breakdown products.

The unstained

PA band cut f ro m an SDS-PAGE gel and left at room temperature for several days was again electrophore sed by SDS PAGE.

Th e stained gel revealed two lower mol ecular wei ght

peptides along with the PA band indicati ng that the two
lower molecular weight peptides are derived from the PA.
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Cell Line Selection
The in vivo distribution of PA* in a susceptible
host, namely Fischer 344 male rats, upon intravenous injection of a PA*/LF mixture is shown in Figure 6.
subject that received the lowest dose

In the

(5 ug PA*), the

highest concentration of PA* was found in the kidney on a
per gram tissue basis, followed by the liver, spleen,
lun g, and heart.

In the rat dosed with 10 ug PA*, the

highe st concentration of PA* was found in the spleen ,
followed by the kidney, liver, lung , blood, and heart.

In

the anima l receiving the 20 ug dose , the highest concentration of PA* was in the spleen , followed by the liver,
kidney, lung, blood, heart, and brain.

The thyroid showed

next to the least activity the anima l receiving the 10 ug
PA* dose.
From these results and the implication of the kidney
in the pathology of anthrax disease, it was decided to use
an established kidney cell line from a susceptible ho st
species for the following experiments .
Protective Antigen
Binding Experiments
Labelling of PA for in-vitro binding studies.
Upon
125
I/PA mixture,
completion of the gel filtration of the
aliquots of the collected fractions were assayed for radioactivity.

Two we ll -defined peaks were observed (Fig. 7) .

The first peak represented the PA* and the second repre125
sented free
I.
Th e PA* had a specific activity of
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~
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125
Fig. 6. In vivo distribution of
!-labelled protective antigen (PA*). The different amounts of PA* with the amounts of lethal factor (LF) shown were injected iv
into 3 different Fischer 344 rats.
The rats were sacrificed at 15 min, perfused,
and the organs removed, rinsed, weighed, minced, and then assayed for radioactivity.
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approximately 1 pCi/ug.

The fractions representing the

PA* were pooled for use in the binding experiments.
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Fig. 7. Gel filtration of
!/labelled protective
antigen (PA*) mixture. After radio-iodination of PA,
the radioactive iodine/PA* mixture was chromatographed
through a G-50 fine sephadex column . Fractions of eluent
were collected in separate tubes and assayed for radioactivity. The first peak represents the PA* and the
second peak represents free radioactive iodine.
125
Dissociation of

I

and PA.

Fractions collected

from the gel filtration of PA* labelled 8 days earlier
showed gamma activity in two well-separated peaks demon125
I from the PA* (Fig.
strating the dissociation of the
8).

During the time from day 0 to day 8 it was determined
125
that approximately 20% of the total
I had dissociated
from the PA*.
and

A linear rate of dissociation was assumed

subsequently used in calculating specific activity

for experiments requiring it.
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Fig. 8. Dissociation of
I and protective antigen (PA).
Eight days after radiolabelling, an aliquot of PA* was gel
filtered on a G-50 fine sephadex column. Fractions were
collected in separate tubes and assayed for radioactivity.
Two well-separated peaks are evidence of dissociation of
radioiodine from labelled PA.
Effect of concentration of unlabelled PA on the
binding

of PA*.

The total cell-associated radioactivity

after a 1 hr exposure to PA* at 500 ng/ml was designated
100%.

The same concentration of PA* in the presence of a

10-fold excess of unlabelled (cold) PA decreased the total
binding of PA* to nearly 30% (Fig. 9).
Increasing the

cold PA to a 100-fold excess de-

creased the total binding to just under 19%.
in total binding reached 83.8% with a 500-fold
cold PA.

The decrease
excess of

A 100-fold excess of cold PA was used in all sub-

sequent experiments to ensure minimal nonspecific binding.
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Fig. 9. Effect of excess unlabelled protective antigen
{PA) on binding of PA* to MDBK cells. MDBK cells were
treated with PA* at 500 ng/ml alone or with excess unlabelled PA for 1 hr. All treatments were then rinsed
and assayed for radioactivity.
Incubation at 37°C.
Error bars represent standard error of the mean.
Binding of PA* at various concentrations.

Initially,

24-well plates were used to demonstrate saturation by
varying the concentration of PA*.

When saturation was not

observed at 2500 ng PA*/ml, 96-well plates were substituted for the 24-well plates since the available PA* was
limited.

Fifty microliters was used as a treatment volume

rather than the 300 pl required by the 24-well plates.
This volume reduction corresponded proportionately with
the reduction in cell monolayer surface area. Saturation
of binding sites on the MDBK cells was then attempted by
increasing the high end of the concentration range to 5000
ng PA*/ml for 1 hr.

The same experiment was repeated for

50

Fig. 10. Effect of concentration of labelled protective
antigen (PA*) on its binding to MDBK cells. MDBK cells in
triplicate wells were treated with PA* at various concentrations with corresponding controls for 5 hr at 37°C
and 4°C. After this time the cell sheets were rinsed and
assayed for radioactivity. Variance among wells
representing total binding averaged 13% at 37°C and 24% at
4°C. Valiance among control wells averaged 7% at 37°C and
74% at 4 C.
The binding experiment at 4°C appeared to give lower
levels of cell associated radioactivity than that at 37°C.
At 5000 ng/ml it still did not appear that saturation
was achieved in 5 hr.

The treatment of cells over a 10 hr

period with PA* concentrations as high as 5300 ng/ml
demonstrated saturation at about 3752 ng/ml

(Fig. 11).

The number of binding sites was 72,000 per cell.
Binding of PA* over time.

Initial experiments to

determine binding of PA* at 2500ng/ml

(Fig. 12) showed

that saturation was being approached at about 12 hr.
rise in CPM/well occurred at 7 hr which was also noted
in a subsequent experlment alth o ugh less pronounced.

A
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Fig. 11. Effect of concentration of la belled PA (PA*) on
binding to MDBK cells.
MDBK cells in triplicate wells
were treated with PA* at varying concentratio ns with corresponding controls for 10 hr at 37°C . After this time
the cell sheets were rinsed and assayed for radi oactivity .
Data is from 3 separate experiments (data point s at 3550
and 5300 ng PA*/mL are from 2 experiments) . Error bars
represent standard error of the mean .

Fig. 12. Binding of lab elled protective antigen (PA*) to
MDBK cells over time (PA* at 2500 ng/ml). At timed intervals triplicate wells were r insed and assayed for radioactivity along with 1 set of contro ls.
Performed at 37°C.
Variance in wells re p r esenting tota l binding averag ed 5%.
Variance in control wells averaged 9% . Note outlier at 7
hr.
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In the following experiments cell-density-per-well
counts were made at each assay time to account for the
possibility that the rise noted in the curve at 7 hr (Fig.
12) could be due to cell division.

Binding of PA* at 3000

ng/ml over time (Fig. 13) with accompanying cell counts
failed to manifest the rise and showed saturation after 15
hr.
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Fig. 13. Binding of labelled protective antigen (PA*) to
MOBK cells over time (PA* at 3000 ng/ml). At timed intervals 1 set of 3 wells was rinsed and assayed for radioactivity along with 1 set of controls. Upper graph shows
concentration of cells per well at same time intervals.
Data is from 3 separate experiments at 37°C. Error bars
represent standard error of the mean.
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Reversibility.

Cells treated with unlabelled PA

after preloading with PA* for 6 hr resulted in an initial
rapid loss of bound PA* in the first 15 min (Fig. 14) with
a slower but linear rate of release for the remaining 2 hr
of the experiment.
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Fig. 14. Reversibility of labelled protective antigen
(PA*) binding to MDBK cells over 2 hr. MDBK cells in
triplicate wells were treated with PA* at 2500 ng/ml for 6
hr at which time one set of wells was assayed and designated 100% binding. The treatment volume in the other
sets of wells was replaced with unlabelled PA at 2000
ng/ml and the wells were rinsed and assayed in triplicate
at timed intervals.
Incubation was at 37°C. Variance
among wells representing total binding averaged 9%.
Variance among controls wells averaged 18%.
Assays over longer periods of time under the same
conditions (Fig. 15) demonstrated the same result with
rapid initial release of PA* and then a slower rate of
release over a 17 hr period.
Binding affinity of PA*.

The Scatchard analysis of

binding data of PA* to MBDK cells revealed a dissociation
-9
constant (K ) of 17 x 10
M PA* (Figure 16).
D
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Fig. 15. Reversibility of labelled protective antigen
(PA*) binding to MDBK cells over 17 hr. MDBK cells were
treated with PA* at 2187 ng/ml for 6 hr at which time 1
set was rinsed and assayed. This was designated 100%
binding. The treatment volume in the other sets of wells
was replaced with unlabelled PA at 2000 ng/ml and the
wells were rinsed and assayed in triplicate at timed
intervals. Parallel sets of wells without the treatment
volume replaced with unlabelled PA were also assayed at
timed intervals and showed saturation at the 11 hr mark.
Incubation was at 37°C. Variance among wells representing
total binding averaged 13%. Variance among control wells
averaged 17%.
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Fig. 16. Scatchard analysis. Binding data from
saturation experiments was used to generate the points
for the Scatchard analysis. Bound (B) toxin in nanomolar
values is plotted on the abscissa and the bound/free (B/F)
ratio is plotted on the ordinate. The line (-0.06 slope)
was fitted by regression analysis (r = -.7).
Effect of Trypsin Treatment on Binding of PA*
Treatment of cells with trypsin at 0.15% and EDTA at
0.1% for more than 20 sec resulted in severe loss of the
cell sheet due to detachment of the cells.
was therefore limited to 20 sec or less.

Trypsin/EDTA
At 10 sec of

trypsin/EDTA treatment the cells showed a "rounding-up" of
the individual cells characteristic of trypsin treatment.
This indicated that the protein molecules on the surface
of the membrane responsible for attachment to the plastic
well had been acted upon by the trypsin.

The cell sheets

utilized in the experiment sustained a loss of about 5-10%
of the cells in 1 or 2 of the 3 wells in each set.
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By one-way analysis of variance, the effect of the
trypsin on the binding of PA* to MBDK cells was shown to
be insignificant (p>O.OS)
1000

BOO

(Fig. 17).
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Fig. 17. Effect of trypsin treatment of MDBK cells on the
binding of la belled protective antigen (PA*). MDBK cells
in triplicate wells were treated with a solution of 0.15%
tr6psin and 0.1% EDTA (pH 7.0) for 10, 15, and 20 sec at
25 C. The cells were then rinsed twice with MEM containing 20% fetal bovine serum. After 20 min the cells
were rinsed and treated with PA* at 3000 ng/ml. Parallel
untrypsinized cells with controls were also treated with
PA*. All wells were rinsed and assayed after incubation
for 45 min at 37°C.
PA- = unlabelled PA. Error bars
represent standard error of the mean.
Blocking of PA* Binding
with Cholera Toxin Subunit B
The binding of PA* to MBDK cells was shown to be
blocked by the cholera toxin subunit B (Fig. 18).

The

degree of blocking appeared to be concentration dependent
with about 10% binding reduction at a 0.1 molar ratio of
cholera toxin subunit B and nearly 50% reduction at a 50
fold excess of subunit B.
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MOLAR EXCESS CHOLERA TOXIN SUBUNIT B

Fig. 18. Blocking effect of chol e ra toxin subunit B on
binding of labelled protective an t igen (PA*). MDBK cells
in triplicate wells were treate d with varying concentrations of cholera toxin subun i t B or medium with or without
unlab e lled PA for 105 min. PA* was then added to each
well to achieve 2500 ng/ml and the n incubated for 2 hr.
All cells were rinsed and assayed .
Incubation was at 37°C .
PA- = unlabelled PA. Error bars represent standard error
of the mean.
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DISCUSSION
It is well established that toxins bind to cell
surface receptors in order to exert their effects.

This

research has attempted to obtain pure protective antigen
component of the anthrax toxin and to characterize its
·binding interaction with an estab lished cell line.
Toxin Production
and Purification
The pathogenic B. anthracis Vollum lB strain was used
for toxin production initially.

Biological activities of

the toxin were successfully demonstrated.

Lethality was

demonstrated by intravenous injection of Fischer 344 male
rats with sterile crude and concent rated toxin as well as
purified PA and LF components.

Subcutaneous injection of

crude and concentrated toxin into rabbits was used to
manifest the edema response.

Times to death (TTD) were

routinely as low as, or lower, than those reported by
Haines et al.

(1965) for crude toxin or by Ezzell et al.

(1984) for purified components.
It was subsequently determined that the Sterne vaccine strain of B. anthracis produced toxin which possesed
essentially the same degree of lethality for test animals.
It is genera lly accepted that the aviru l ence exhibited by
the Sterne strain is due to the lack of a capsule .

For
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safety considerations, therefore the majority of PA production for binding experiments was derived from B. anthracis
Sterne strain.
In the early work with anthrax toxin, horse serum was
added to the culture supernatant to prevent the adsorption
of anthrax toxin onto the filters used (Haines et al.,
1965).

The variety of proteins in the serum would have

considerably complicated the purification of PA for this
research. I.G. Resnick of U.S. Army Dugway Proving Ground
(personal communication) recommended the use of PEG to
minimize toxin losses due to nonspecific binding.

The use

of PEG to minimize filter adsorption proved effective in
this research as evidenced by the toxin yield and it did
not add contaminating proteins to the culture supernatant.
Subsequent dialysis easily removed the PEG.
Purification of the PA component beyond the 90% level
has not been reported in the literature.

Greater purity

levels were considered necessary for the proposed binding
studies in order to eliminate possible interference from
contaminants.

Efforts in this research succeeded in yield-

ing purified PA at levels > 99% as revealed by SDS-PAGE
with coomassie blue and silver staining.

The purified PA

maintained biological and antigenic activity as demonstrated by lethality in combination with LF and by immunoelectrophoresis against anti-PA antibodies and anti-whole
cell antiserum.
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The approach used to accomplish the PA purification
differed from that used by Leppla (1982 & 1984) whose
purification sequence involved 1) dilution of crude toxin,

2) batch adsorption to DEAE-cellulose, 3) elution followed
by ammonium sulfate precipitation, 4) dialysis, 5) HTP
chromatography with an elution gradient of 0.002 M to 0.5 M
TM
KH PO , 6) dialysis, and 7) DEAE Trisacryl-M
(LKB,

2

4

Bromma, Sweden) chromatography.

In this research the

sequence for purification was 1 ) concentration of crude
toxin in an Amicon (Danvers, MA.) stirred concentrator
cell, 2) dialysis, 3) HTP chromatography with an elution
gradient of 0.002 M to 0.4 M KH PO , 4) dialysis (or gel
2
4
filtration), and 5) DEAE-cellulose with Cellex-D chromatography.
The culture volume used also differed.

Leppla (1982

& 1984) used a 20 L fermentor whereas only 1/2 L cultures
in flasks were used in this research.

Use of a smaller

culture volume without agitation may minimize cell lysis
which could add contaminating proteins.
Contamination by proteins contributed by lysis of
older cells in the culture may also have been minimized by
harvesting as early as possible during the recommended
time period

(Haines et al. 1965). Elimination of the

centrifugation step, used to pellet the bacteria before
filtration, also minimized cell lysis due to manipulation
of the supernatant.

Use of a pre-filter prevented the

0.22 urn filter from clogging, thereby eliminating the
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centrifugation step. As noted, this method showed no
apparent reduction in toxin yield.

Elimination of smaller

molecular weight contaminants was also achieved by the
concentration step in the Amicon cell

~~th

a 30,000 MW

exclusion limit and by utilizing a 50,000 MW exclusion for
the dialysis tubing.
Analysis of the fractions from HTP and DEAE chromatography consistently revealed 2 contaminants of about
30,000 and 50,000 MW which proportionately paralleled PA
in amount in each fraction.
suspected.

Breakdown products of PA were

Subsequent experiments demonstrated this sus-

picion to be true.

Their combined approximate molecular

weights and elution pattern were consistent with the assumption that they were derived from PA.

This fact made it

difficult to obtain purified PA without these contaminating bands.

Again, shortening the culture time may mini-

mize this problem.
Quickly processing the crude toxin from one step to
the next without long intervening periods of storage or
refrigeration is important in eliminating possible action
on the toxin components by enzymes that may be present.
Also, it was noted by Wilkie and Ward (1967) that biological activity of their anthrax toxin was lost in PO
buffers.

4
However, this problem was not observed in the

present study.

Machuga et al.

(1986) reported purifica-

tion of the LF to the 99% level by immunosorbent chromato-
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graphy.

This technique may prove useful in the future

purification of all three factors of the anthrax toxin.
One concern, however, regarding this technique is that if
the breakdown products of PA retained their antigenicity
with respect to the antibodies used in the immunosorbent
chromatography column, they would likely elute with the PA
and be a continuing source of contamination.
The level of purity, as demonstrated by SDS-PAGE,
achieved by Machuga et al.

(1986) may be in question.

It

must be pointed out that the amount of LF run on the
electrophoresis gel by Machuga et al.

(1986) appeared to

be just above the levels of detection by the staining
method used (silver staining).
were 0.25

~g,

If the level of detection

then 2.5 pg would have to run on the gel and

be free of contaminants in order to be declared at > 90%
purity.

This was apparently not the case with the gel

they used to demonstrate purity.
In this research project the purified PA was electrophoresed at high and low concentrations in order to visualize both low level contaminants and masked bands near the
PA respectively.

The LF from the HTP column in this study

appeared >90% homogeneous on SDS-PAGE and when further
purified by ion-exchange chromatography,approached the
same level of purity as the PA (99%).

The LF was anti-

genically free of PA and was suitable for use in the
lethality assay.
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Protective Antigen Labelling
125
The use of
I in the labelling of ligands has found
wide use in binding studies.

This technique allowed for a

more direct assay system with fewer steps and complications compared to radiologically labelled anti-PA or a
fluorescence assay for example.

The PA failed, however,

to take up the label to a great enough specific activity
(CPM/ug protein) for the sensitivity required in the binding studies.

Therefore, it was decided to enhance the

labelling process by use of the Bolton-Hunter reagent.
This additional technique has been reported in a number of
other binding studies

(Morris et al., 1980; Kitamura et

al., 1980; and Rogers and Snyder, 1981).

With the Bolton-

Hunter reagent, the PA was labelled to levels above 1
uCi/ug protein.

This corresponded to levels commonly

found in the literature and was suitable for use in the
96-well tissue culture dish assay.

Higher levels of

labelling may subject the ligand to deterimental effects
from the isotope's energy of disintegration.
125
Dissociation of
I from the PA was observed over
time.

This phenomenon does not seem to be universally

considered in binding studies utilizing labelled ligand.
Failing to consider this occurrence could give misleading
quantitative results.
The PA* was routinely utilized within 10 days of
labelling and was kept on ice during that time.
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In Vivo Study and
Cell Line Selection
Wider use of cell culture in research has enhanced
understanding of how toxins exert their effects
(Solotorovsky and Johnson, 1970).

Selection of the ce ll

line for this study involved an experiment to determine
which organs of a susceptible host might serve as targets
for the anthrax toxin.

Cattle and sheep which are

naturally susceptible hosts to anthrax were impractical
and too expensive to use.

Although the Fischer 344 rat is

relatively resistant to infection with B. anthracis
(Stephen and Pietrowski, 1983), it is extremely sensitive
to the anthrax toxin.

This made the Fischer 344 rat a

suitable choice for the in vivo study.
The in vivo distribution of PA* directed the decision

-- ----

as to what type of cultured cells would be used for the
binding studies .

Although the kidney and lung tissues

showed less radioactivity after exposure to the labelled
PA than the spleen or liver at the 20 pg leve l, the kidney
showed the highest activity at the 5 pg level implying
that PA may initially be se l ectively adsorbed by kidney
tissue.

The kidney and lung have been implicated in the

lethality of anthrax infection (Nalin et al., 1977; Smith
and Stoner , 1967; Smith and Keppie, 1954).
al.

(1978)

Middlebrook et

in studies with diphtheria toxin noted that of

seven ce ll lines tested, the three most sensitive in their
battery were derived from kidney tissue .

They (Middlebrook
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et al., 1978) also cited Solotrovsky and Gabliks' observation that among the most toxin sensitive cell lines were
primary kidney cells.

In view of these observations and

the fact that cattle are a susceptible and primary host of
anthrax, the MDBK cell line was chosen.

It is seen in

this project that receptors for PA are present on MDBK
cells in significant numbers.

This suggests a potential

susceptibility of MDBK cells to either EF or LF.

This

possibility merits further investigation.
An interesting point regarding the in vivo study was
that the blood contained very little of the radioactive
PA* after 15 min indicating a rapid removal of the PA from
circulation.

This substantiates a similar observation by

Molnar and Altenbern (1963).
Binding Assay
In preparation for performance of the in vitro testing, an assay system to monitor the presence of PA* was
developed.

The assay proved successful for the parameters

investigated.

The specific activity of 1 pCi/ug protein

allowed rapid and simple quantification of nanogram quantities of PA* with statistical precision in the in vitro
system.

The assay had good reproducibility between trip-

licate wells with generally less than 15% variation and a
high specific/non-specific ratio of cell-associated radioactivity.

The cost of about $100.00 per 30 pg PA labelled

is reasonable and provides enough PA* to conduct numerous
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experiments at high concentrations of PA* (2000 - 5000
ng/ml).
Evaluation of Experimental
Results for Receptor Criteria
The purification of PA to required levels and the
development of a reliable assay system were critical steps
to provide the tools for the binding studies performed.
The criteria for identifying the receptor(s) for PA* on
MDBK cells were investigated (i.e. specificity, saturability, reversibility, and affinity).
Specificity.

It has been noted by Middlebrook et al.

(1978) and Aguet et al.

(1982) that competition between

unlabelled ligand and labelled ligand

for a receptor is a

demonstration of receptor-ligand specificity.

The binding

of PA* was significantly reduced (approximately 70%) by
the presence of a 10-fold excess of unlabelled PA in 1 hr
of treatment, in 24-well plates (Fig. 9).

These results

are particularly significant in that the larger 24-well
plates would accomodate greater numbers of possible nonspecific binding sites for the PA*.

It should also be

noted that the 10% level of FBS in the treatment volumes
not only aided in stabilizing the PA, but also could have
blocked possible nonspecific binding.
Blocking of PA* binding by cholera toxin may also be
considered evidence of the specificity of the binding of
PA* to the MDBK cell receptor(s).
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Saturability.

The saturation of binding sites at 37°

C with labelled PA at 3000 ng/ml over time (Fig. 12) as
well as during the 10-hr

saturation study at varying

concentrations of PA* (Fig. 11) demonstrated that a limited number of binding sites are available on the MDBK
cell surface.

This also suggests that the PA remains
125
I is not
bound and unprocessed or at least that the

rapidly endocytosed with the PA being cleaved and excreted
125
!-diphtheria toxin at 37°C

as is the case with

(Middlebrook et al., 1978).
Calculations of receptor number per cell based on the
saturation levels from the 10-hr concentration study (Fig.
11) and the time study (Fig. 12) showed about 72,000 and
114,000 receptors for PA per cell respectively.

It must

be borne in mind that the cell surface available for
binding PA is highly reduced because cells are grown in
monolayer rather than suspension.

Therefore, the actual

number of receptors per cell may be double the amount
cited here.

This number of binding sites assumes a PA to

receptor ratio of one.
Ezzel et al.

(1984) noted that the minimum amounts of

PA and LF for lethality in Fischer 344 rats are 3 pg and
0.6 pg respectively.

They cautiously suggest that a pos-

sible 5:1 ratio may exist between PA and LF with regard to
pathological and/or receptor function .

The prolonged time

to saturation noted in Figs. 12 and 13 may be partly
accounted for by the possibility of formation of PA* to
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PA*-receptor aggregates.
been reported.

Aggregation of this type has

Insulin, for example, has been shown to

display this characteristic (Cuatrecasas and Hollenberg,
1975) •

Internalization of the PA* could also explain the

apparent prolonged time to saturation particularly at 37°
C.

At this temperature the normal dynamic functions of

the cell such as endocytosis would be fully operable.
Middlebrook et al.

(1978) have shown that internalization

occurs with labelled diphtheria toxin.

The graphic repre-

sentation of their data shows a rise and then a significant fall in cell-associated radioactivity over time.

The

processing and excretion of the labelled A (active) subunit of the diphtheria toxin from cells may explain the
decrease in cell-associated radioactivity noted as the
cleaved toxin subunit would likely be incapable of reassociating with the cell.

However, no such fall in cell-

associated radioactiviy was noted
over time.

with the PA* binding

Leppla (1982) observed that the delivery

mechanism (presumably the PA-receptor complex) of EF to
its site of action in the cell did not appear to be used
up thus indicating the reusability of the bound PA for
internalization of the EF.

Gill

(1978) observed that the

"B" or binding subunits of toxins are probably not internalized.

These observations suggest that internalization

of PA, which functions as a binding subunit, probably did
not contribute substantially to the prolonged saturation
time noted in this research for PA binding to MDBK cells.
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An observation wo rth n o t i ng in the 21-hr saturation
study for PA binding (Fig. 13) is an apparent saturation
at two stages (9 and 18 hr).

The levelling off of

radioactivity per cell after 9 hr occurs just prior to
an increase in the cell count per well.

A subsequent

increase in radioactivity per cell was detected after 15
hr suggesting an increase in receptors per cell.

This

po ssible increase in receptors per cell is compatable with
observations reported by Koulakoff et al.

(1983) who noted

that the ganglioside receptors on neuronal cells for tetanus toxin were expressed about 7 hr following the S phase
of mitotic division.

The apparent saturation of PA recep-

tors at about 9 hr and subsequent binding increase may be
indicative of delayed receptor expression.

Delayed

expression of receptors, then, is a process which must be
considerecl in quantitative ligand binding studies.
Reversibility.

The binding of PA* to MDBK cells was

shown to be a reversible event in Figs. 14 and 15 with the
rapid initial release of bound PA*.

The slower rate of

release that followed the initial drop in cell associated
radioactivity may be due to a low dissociation rate following a time threshold.

That is, after a certain amount of

time, the PA* may be more firmly associated with (or
perhaps imbedded into) the cell membrane.

Another explan-

ation for the slower rate of release of cell-associated
radioactivity could be the release of internalized PA*.
However, if this were so, it would seem that a sharper
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drop in bound PA* should be observed.
Affinity.

Data from the 10-hr saturation study (Fig.

11) was used to do Scatchard (1949) analysis.

The binding

-9
constant (K ) for PA* derived therefrom was 17 x 10

M.

D

This relatively low constant is consistent with the greater
length of time and higher concentrations required to
obtain saturation.

The K

derived for PA* in this study

D

was found to be much higher than that reported for
diphtheria (Collier, 1975; Middlebrook et al., 1978),
cholera (Bresson et al., 1984), tetanus (Rogers and
Snyder, 1981), or enterotoxin
1982) as shown in Table 3.

of~

coli (Donta et al.,

It should be noted that the

dissociation constant for toxin binding may be temperature
dependent (Sandvig et al., 1976).
TABLE 3
COMPARISON OF TOXIN DISSOCIATION CONSTANTS
Dissociat~on

Toxin

Cell type

constant (KD)
-9

Protective antigen

MDBK

17.0

X

10

a

M
-9

Tetanus

mammalian brain

1.2

X

10

M
-9

Cholera

rabbit intestine

1.2

X

10

M
-9

enterotoxin
E. coli
--Diphtheria

Y1 adrenal

0.6

X

10

mammalian

10.0

X

10

-9

~Performed at 0°C
Performed at 4° C

M
-9

b

Diphtheria

M

Vero

1.1

X

10

M
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It has been reported by Gill

(1982) that a greater

amount of anthrax toxin is required for lethality than
that of other toxins such as those from

~

tetani, and Corynebacterium diphtheriae.

botulinum,
If the K

~

deter-

0

mined here for PA* is similar to that found in vivo, it
could offer a reasonable explanation for this requirement.
However, it is acknowledged that lethal dose is also
dependent upon mode of action.

For example,

a neurotoxin

such as that produced by C. botulinum will induce more
life-threatening results than a toxin that causes diarrhea.
Based on available results, it appears that the binding of PA* is linear on the Scatchard plot suggesting a
single receptor model.

The fitted line for the Scatchard

analysis (Fig. 16) had a correlation value (r) of -0.7.
However, the possibility of a curvilinear relationship
should not be overlooked which could indicate the existence of more than one receptor or the aggregation of PA*
to already bound PA* as noted earlier.

It needs to be

considered that the affinity of PA* for MDBK cells may
possibly be enhanced by such cofactors as divalent cations
or perhaps even the presence of LF or EF.

This would be a

possibility for future investigation.
Other suggestions can be made for further evaluation
of receptor criteria for PA*.

Lin and Taniuchi (1980)

reported use of chemicals which block receptor internalization and lysosomal processing but which still allow
binding of cholera toxin.

This approach might be of value
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in assessing the degre e to which internalization, if any,
of PA* may have taken place.

It was felt in this research

that it was of greater value to conduct experiments at
physiological temperatures in order tc more closely simulate the in vivo situation.

Although saturation studies

performed at 4°C could have minimized possible internalization of PA*, the lower temperature may also have given
misleading results in that the membrane fluidity of cells
and hence the degree to which receptors may be displayed
is greatly influenced b y temperature (Sheeler and Bianchi,
1983) •
Partial Characterization of
Protective Antigen Receptor
It is well established that many toxins bind to
gangliosides (Kitamura et al., 1980; Morris et al., 1980;
Rogers and Snyder, 1981; Osborne et al., 1982; and Eidels
et al., 1983).

Cholera is one such toxin and its B sub-

unit is available for purchase in purified form.

It

seemed a logical selection, therefore, for use in a blocking experiment against PA*.

Cholera toxin subunit B was

demonstrated to effectively block the binding of PA* to
MDBK cells.

The blocking was shown to be concentration

dependent. This observation strongly suggests that at
least one of the PA* receptors is the GM 1 ganglioside.
It should not be discounted, however, that the cholera
toxin-receptor complex may be located near the receptor
for PA* and thereby stearically hinder the binding of PA*.
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Trypsin treatment was shown to have no effect on the
ability of the MDBK cells to bind to PA*.

This would be

expected if PA* receptors are gangliosides since gangliasides are not proteins.

Cuatrecasas (1973) showed that

trypsin had no effect on the binding of cholera toxin to
liver cells.

Yavin and Nathan (1986), however, demon-

strated trypsin sensitivity in the binding of tetanus
toxin to nerve cells, whose receptors are also gangliasides (Kitamura et al., 1980).

Yavin and Nathan (1986)

concluded that the trypsin sensitivity

was due to the

sensitivity of a protein closely associated with the ganglioside receptor and which may serve to contribute greater
specificity to the receptor.

The observation that trypsin

treatment had no effect on PA* binding suggests that there
is no protein associated with the receptor which is critical for PA* binding.
Practical Applications
The purification of PA beyond the 99% level enhances
the capability of producing high affinity antibodies, both
polyclonal and monoclonal.
Development of the assay system used in this research
to quantitate the presence of PA* should prove useful in
future research with the anthrax toxin components.
Any study which contributes to the understanding of
the nature of bacterial toxins and how they exert their
effects is of value.

With understanding of how something
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works comes the potential for making that thing useful.
Great interest recently has stimulated work in the area of
hybrid molecules for potential use in medicine or research
(Colombatti et al., 1983; Blythman et al., 1981; Krolick
et al., 1980; Moolten et al., 1982; Gilliland et al.,
1980; Olsnes, 1981; and Roth and Maddux, 1983).

A hybrid

molecule might, for example, have the active subunit of a
toxin coupled to an antibody against a cancer cell for use
in cancer therapy.

Obviously specificity, stability of

the molecule, and the capability of delivering the toxic
portion intracellularly are primary considerations.

Pro-

tective antigen provides another potential binding subunit
that, with modification, could deliver toxic molecules to
specific target cells.
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CONCLUSIONS
From the experimental data

obta~~=C

in this research

the following conclusions can be mace:
1)

Use of the Sterne strain of B. anthracis yields

toxin comparable in lethality to that of the Vellum 1 B
strain and minimizes the biological hazard associated with
the culturing
2)

of~

anthracis

Higher yields of PA can be obtained by use of PEG

to minimize nonspecific binding of the toxin to the filter
during filtration.

Use of PEG also minimizes contamina-

tion by serum proteins which were previously used
to block nonspecific binding.
3)

PA can be purified to levels > 99%.

4)

The radioassay system which has been developed is

suitable for PA* binding studies.
5)

Binding of PA* to MDBK cells exhibits specificity,

saturation, reversibility and moderate affinity.

These

results verify the presence of a specific receptor(s) for
PA* on MDBK cells.

Specificity was demonstrated by compe-

tition of unlabelled PA, cholera toxin subunit B, and the
serum proteins in the 10% fetal bovine serum of the treatment medium.

Saturation of the potential binding sites

was shown by two methods:

over time at a set concentra-

tion of PA* and by varying the concentration of PA* with a
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set treatment time .

Reversibility was demonstrated by the

fact that about 25% of bound PA* was removable within 15
min of treatment with unlabelled PA.

Affinity, although

not as high as that reported for other toxins, was demon-9

strated for PA* with a K of 17 x 10
M.
D
It is likely that the receptor for PA* on MDBK
6)
cells is a ganglioside as indicated by cholera toxin
subunit B blocking in conjunction with lack of trypsin
sensitivity.

77

LITERATURE CITED
Aguet, M. and Blanchard, B. (1981).
High affinity binding
of 125I-labeled mouse interferon to a specific cell
surface receptor. II. Analysis of binding properties.
Virology 115, 249-261.
Aguet, M., Belardelli, F., Blanchard, B., Marcucci F., and
Gresser, I. (1982).
High-affinity binding of 125rlabelled mous e interferon to a specific cell surface
receptor. Virol ogy 117, 541-544.
Alouf, J.E. (1977). Cell membranes and cytolytic bacterial toxins.
In The Specificity and Action of Animal,
Bacterial and Plant Toxins (P. Cautrecasas, ed.), pp.
2212-264. ~lsted Press, New York.
Alving, C.R., Iglewski, B.H., Urban, K.A., Moss J.,
Richards, R.L., and Sadoff J.C. (1980). Binding of
diphtheria toxin to phospholipids in liposomes.
Proc. Natl. Acad. Sci. USA.
77, 1986-1990.
Beall, F.A., Taylor, M.J., and Thorne, C.B. (1962).
Rapid
lethal effect in rats of a third component found upon
fractionating the toxin of Bacillus anthracis. J.
Bacterial. 83, 1274-1280.
Belton, F.C. and Strange, R.E. (1954). Studies on a protective antigen produced in vitro from Bacillus
anthracis, Medium and method~production. Br. J.
~ Pathol.
35, 144-152.
Bhakdi, S., Muhly, M., and Fussle, R. (1984). Correlation
between toxin binding and hemolytic,activity in membrane damage by staphylococcal alpha-toxin. Infect.
Immun.
46, 318 -323.
Blythman, H.E., Casellas, P., Gros, 0., Gros, P., Jansen,
F.K., Paolucci, F., Pau, B., and Vidal, H. (1981).
Immunotoxins, Hybrid molecules of monoclonal antibodies and a toxin subunit specifica lly kill tumour
cells. Nature 290, 145-146.
Bonventre, P.F. and Kempe, L.L. (1960). Physiology of
toxin production by Clostridium botulinum types A and
B.
I. Growth autolysis and toxin production. J.
Bacterial.
79, 18 - 23.
-

78
Bonventre, P.F. (1965).
Differential cytotoxicity of
Bacillus anthracis and Bacillus cereus culture filtrates. J. Bacterial.
90, 284-2~
Bonventre, P.F. (1970). The nomenclature of microbial
toxins, Problems and recommendations. In Microbial
Toxins I. (S.J. Ajl, s. Kadis, and T.C. Montie,
eds.), Vol. I. pp. 29-62. Academic Press, New York.
Boquet, P. and Duflot, E. (1981).
Studies on the role of a
nucleoside-phosphate-binding site of diphtheria toxin
in the binding of toxin to vero cells or liphosomes.
Eur. ~ Biochem. 121, 93-98.
Bresson, J.L., Pang, K.Y., and Walker, W.A. (1984). Microvillus membrane differentiation, Quantitative difference in cholera toxin binding to the intestinal
surface of newborn and adult rabbits.
Pediatr. Res.
18, 984-987.
---Buchanan, R.E. and Gibbons, N.E. (1974).
Bergey's Manual
of Determinative Bacteriology. The Williams and
Wilkins Company, Baltimore.
Clemens, M. (1984). Enzymes and toxins that regulate protein synthesis. Nature 310, 727.
Collier, R.J. (1975). Diphtheria toxin: Mode of action and
structure. Bacter ial. Rev.
39, 54-85.
Collier, R.J. (1977).
Inhibition of protein synthesis by
exotoxins from Corynebacterium diphtheriae and
Pseudomonas aeruginosa. In The Specificity and Action
of Animal, Bacterial and Plant Toxins (P. Cautrecasas,
-ed.), pp. 69-98. HalSted Press, New York.
Colombatti, M., Nabholz, M., Gros, 0., and Bron, C. (1983).
Selective killing or target cells by antibody-ricin A
chain or antibody-gelonin hybrid molecules: Comparison of cytotoxic potency and use in immunoselection
procedures. ~ Immunol. 131, 3091-3095.
Craig, J.P., Yamamoto, K., Takeda, T. Takeda, Y., and
Miwatani, T. (1981). Vascular permeability activity
of Escherichia coli heat-stable enterotoxin.
Infect.
Immun.
33, 473-476.
Critchley, D.R., Magnani, J.L., and Fishman, P.H. (1981).
Interaction of cholera toxin with rat intestinal
brush border membranes. ~ Biol. Chern. 256, 87248731.

79
Critchley, D.R., Streuli, C.H. , Kellie, s., Ansell, s., and
Patel, B. (1982) . Characterization of the c holera toxin
receptor. Biochem. ~ 204, 209-219.
Critchley, D.R., Nelson, P.G., Habi g , W.H., and Fishman,
P.H.
(1985).
Fate of tetanue toxin bound to the
sur fa ce of primary neurons in c ulture: Evidence for
rapid inte rnali zatio n . ~Cell Biol. 100, 1499-1507.
Crutchley, M.J., Marsh , D.G., and Cameron, J. (1968). Biol ogica l studies o n free e ndotox in and non-toxic material from cu l ture supe rnatant fluids of Escherichia
co li 078K80 . ~Gen. Mi crobia l. 50, 413 420.
Cuatr ecasas , P.
(1973).
Interaction of Vibrio c holerae
enterotoxin with ce ll membranes. BIOChemistry 12,
35 47-3 558 .
Cuatr ecasas , P.
(1974). Membrane receptors.
Biochem .
43, 1 69 - 213 .

Ann. Rev.

Cuatrecasas, P. and Hollenberg, M.D.
(1975). Binding of
insu l in and other hormones to non-receptor ma te rial s:
Saturability, specificity and appare nt "negati ve" cooperativi ty .
Biochem. Bioph ys . Res. Commun.
62,
31 -41.
Cuatrecasas, P. and Hollenberg, M.D.
(1976). Me mbran e
receptors and hormone action.
In Advances in
Protein Chemistry (C.B. Anfi nsen, J.T. EdsaiT, and
F.M. Richards, eds. ), pp. 251-428. Acad e mi c Press,
Sa n Fr anc isco .
Dalldorf, F.C., Kaufmann, A.F., and Brachman, P.S. (1971).
Woolsorters disease. An experimen tal model. Arch.
Pathol. 92, 418-426.
Davies, D.G . and Harvey, R.W. (1972). Anthrax infection
in bone meal from various cou ntries of origin. ~
~ Camb.
70, 455-457.
DeWolf, M.J.S., Fridkin, M., Epstein, M., and Kohn, L.D.
(1981). Structure-function studies of cholera toxin
and its A and B protomers. ~ Biol. Chern. 256, 54815488 .
Donovan, J.J., Simon, M.I., and Montal, M. (1982).
Insertion of diphtheria toxin into and across membranes:
Role of phosphoinositide asymmetry. Nature 298,
669 -67 2 .
------

80
Donta, S.T., Poindexter, N.J., and Ginsberg, B.H. (1982).
Comparison of the binding of cholera and Escherichia
coli enterotoxins to Yl adrenal cells. Biochemistry
21, 660-664.
Dorland, R.B., Middlebrook, J.L., and Leppla, S.H. (1979).
Receptor-mediated internalization and degradation of
diphtheria toxin by monkey kidney cells. J. Biol.
Chern. 254, 11337-11342.
-- ----Dorland, R.B. (1982). The protective mechanism of action
of amines in diphtheria toxin treated vero cells. Can.
J. Microbial.
28, 611-617.
Dreyfus, L.A., and Robertson, D.C. (1984). Solubilization
and partial characterization of the intestinal receptor for Escherichia coli heat-stable enterotoxin.
Infect. Immun.
46, 537-543.
Eidels, L, Proia, R.L., and Hart, D.A. (1983). Membrane
re c eptors for bacterial toxins. Microbial. Rev.
47, 596-620.
Ezzell J.W., Ivins, B.E., and Leppla, S.H. (1984).
Immunoelectrophoretic analysis, toxicity, and kinetics of
in-vitro production of the protective antigen and
lethal factor components of Bacillus anthracis toxin.
Infect. Immun. 45, 761-767.
Fish, D.C. and Lincoln, R.E. (1967). Biochemical and
biophysical characterization of anthrax toxin.
Fed.
Proc.
26, 1534-1538.
Fish, D.C. and Lincoln, R.E. (1968).
In vivo-produced
anthrax toxin. J. Bacterial. 95, 919-924.
Fish, D.C., Mahlandt, B.G., Dobbs, J.P., and Lincoln, R.E.
(1968). Purification and properties of in vitroproduced anthrax toxin components. J. BacteriOT.
95, 907-918.
-Fishman, P.H.
(1980). Mechanism of action of cholera
toxin: Studies on the lag period. ~ Memb. Biol.
54, 61-72.
Fishman, P.H., Bradley, R.M., Rebois, R.V., and
R.O.
(1984). The role of gangliosides in
action of human chorionic gonadotropin and
toxin with murine leydig tumor cells,. J.
Chern.
259, 7983-7989.
--

Brady,
the intercholera
Biol.

Freeman, B.A.
(1979). Burrows Textbook of Microbiology.
W.B. Saunders Co., Philadelphia.

81
Freer, J.H. and Arbuthnott, J.P. (1976).
Biochemical and
morphologic alterations of membranes by bacterial
toxins .
In Me chanisms in Bacterial Toxinology
(A.W.
Bernheime r, ed.), pp. 169 193. John Wiley and Sons,
New York.
Friedman, R.M. and Kohn, L.D.
(1976).
Cholera toxin
inhibits interferon action.
Biochem. Biophys. Res.
Commun.
70, 1078-1084.
Ganser, A.L., Kirschner, D.A., and Willinger, M. (1983).
Gang lioside localization on myelinated nerve fibres
by cholera toxin binding. ~ Neurocytol.
12, 921938.
Gershon, N.D., Smith, R.M., and Jarett, L. (1981).
Computer assisted analysis of ferritin-insulin receptor
sites on adipocytes and the effects of cytoc halasin B
on groups of insulin receptor sites.
J. Memb. Biol.
58, 155-160.
-- ----- ----Gill , D.M. and King, C.A. (1975).
The mechanism of action
of cholera toxin in pigeon erythrocyte lysates . J.
Biol. Chern.
250, 6424-6432.
Gill, D.M.
(1978).
Seven toxic peptides that cross cell
membranes. In Bacterial Toxins and Cell Membranes (J.
Jeljaszewicz and T. Wadstrom, e~), pp. 291-332.
Academic Press, New York.
Gill, D.M.
(1982).
Bacterial toxins: a table of lethal
amounts.
Microbi al. Rev.
86-94.
Gilliland, D.G., Steplewski, A., Collier, R.J., Mitchel,
K.F., Chang, T.H., and Koprowski, H. (1980).
Antibody-directed cytotoxic agents:
Use of monoclonal
antibody to direct the action of toxin A chains to
colorectal carcinoma cells.
Proc. Natl. Acad. Sci.
USA.
77, 4539-4543.
----- -------------Gladstone, G.P. (1946).
Immunity to anthrax: Protective
antigen present in cell-free culture filtrates.
~ ~ Exp. Pathol.
27, 394-418.
Goldman,D.W., Chang, F.H., Gifford, L.A., Goetzl, E.J.,
and Bourne, H.R. (1985).
Pertussin toxin inhibition
of chemotactic factor induced calcium mobilization
and function in human polymorphonuclear leukocytes.
~ Exp. Med.
162, 145-156.
Haines, B.W., Klein, F., and Lincoln, R.E. (1965). Quantitative assay for crude anthrax toxins.
J. Bacterial.
89. 74-83.
--

82
Harris-Smith, P.W., Smith, H., and Keppie,J. (1958).
Production in vitro of the toxin of Bacillus anthracis
previously recogniZed in vivo. J. Gen. Microbial. 19,
91-103.

-

--

-

--

Hartley, J.L., Adams, G.A., and Tornabene, T.G. (1974).
Chemical and physical properties of lipopolysaccharide of Yersinia pestis. J.Bacteriol. 118, 848854.
--Holmgren, J., Lonnroth, I., Mansson, J.E., Svennerholm, L.
(1975).
Interaction of cholera toxin and membrane GMl
ganglioside of small intestine. Proc. Natl. Acad.
Sci. USA.
72, 2520-2524.
Holmgren, J.
(1978). Cholera toxin and the cell membane.
In Bac terial Toxins and Cell Membranes (J.
Jeljaszewicz and T. Wad s trom, eds.), pp. 333-336.
Academic Press, New York.
Hudson, T.H. and Neville, D.M. ,Jr. (1985). Quantal entry
of diphtheria toxin to the cytosol. ~ Biol. Chern.
260, 2675-2680.
Kabir, S., Rosenstreich, D.L., and Mergenhagen, S.E.
(1978). Bacerial endotoxins and cell membranes.
In
Bacterial Toxins and Cell Membranes (J. Jeljaszewicz
and T. Wadstrom, eds.~p. 59 87. Academic Press,
New York.
Kagan, B.L. and Finkelstein, A. (1979). T-AM-Po68 Channels
formed in planar bilayer membranes by mutant diphtheria toxin molecule. Biophys. ~ 25, 181a.
Kaslow, H.R., Cox, D., Groppi, V.E., and Bourne, H.R.
(1981). An Mr = 52,000 peptide can mediate effects of
cholera toxin on adenylate cyclase in intact cells.
Mol. Pharmacal. 19, 406-410.
Katzen, H.M., Soderman, D.O., and Green, B.G. (1981).
Evidence that insulin and concanavalin-A can cobind to solubilized insulin receptors without inhibiting each other. Biochem. Biophys. Res. Commun.
98' 410-416.
Kendall, C . E.
(1959). Occupational anthrax in the U. S.
~ Occup. Med.
1, 174-177.
Keppie, J., Harris-Smith, P.W., and Smith, H. (1963). The
chemical basis of the virulence of Bacillus anthracis.
~ ~ Exp. Pathol.
44, 446-453.

83
Kitamura, M., Iwamori, M., and Nagai, Y. (1980).
Interaction between Clostridium botulinum neurotoxin and
gangliosides. Biochim. Biophys. ACTA 628, 328-335.
Klein, F., Haines, B.W., Mahlandt, B.G., DeArmon, R.E. Jr.,
and Lincoln, R.E. (1963). Dual nature of resistance
mechanisms as revealed by studies of anthrax septicemia. J. Bacteriol. 85, 1932-1038.
Koulakoff, A., Bizzini, B., and Berwald-Netter, Y. (1983).
Neuronal acquisition of tetanus toxin binding sites:
Relationship with the last mitotic cycle. Dev. Biol.
100, 350-357.
Krolick, K.A., Villemez, C., Isakson, P., Uhr, J.W., and
Vitetta, E.S. (1980). Selective killing of normal or
neoplastic B cells by antibodies coupled to the A
chain of ricin. Proc. Natl. Acad. Sci. USA. 77,
5419-5423.
Lad, P.M., Olson, C.V., and Grewal, I.S. (1985). Plateletactivating factor mediated effects on human neutrophil
function are inhibited by pertussis toxin. Biochem.
Biophys. Res. Commun. 129, 632-638.
Laemmli, U.K.
(1970). Cleavage of structural proteins
during the assembly of the head of bacteriophage T4.
Nature 227,680-685.
Lazarovici, P. and Yavin, E. (1985). Tetanus toxin
interaction with human erythrocytes. II. Kinetic
properties of toxin association and evidence for a
ganglioside-toxin macromolecular complex formation.
Biochim. Biophys. ACTA 812, 532-542.
Ledeen, R.W. and Mellanby, J. (1977). Gangliosides and
receptors for bacterial toxins.
In Perspectives in
Toxinology (A.W. Bernheimer, ed.), pp. 15-28. John
Wiley and Sons, New York.
Leppla, S.H.
(1982). Anthrax toxin edema factor, A bacterial adenylate cyclase that increases cyclic AMP
concentrations in eukaryotic cells. Proc. Natl.
Acad. Sci. USA.
79, 3162-3166.
Leppla S.H.
(1984). Bacillus anthracis calmodulindependent adenylate cyclase: Chemical and enzymatic
properties and interactions with eucaryotic cells.
Adv. Cyclic Nucleotide Protein Phosphorylation Res. 17, 189-198.

84
Lietzke,
ing
rat
38,

R. and Un sicker , K. (1983).
Tetanus toxin bindto differ ent morphological phenotypes of cultured
bovine adrenal medullary cells. Neurosci. Lett.
233-238.
-----

Lin, M.C. and Taniuchi, M.
(1980) .
Inhibition of cholera
toxin activation of the,adenylate cyclase system in
intact HeLa cells. ~Cyclic Nucleotide Res .
6,
359-367.
Lincoln, R.E. and Fish, D.C.
(1970). Anthrax toxin. In
Microbial toxins Vol. III (T.C. Montie, S. Kadis, and
S.J. Ajl, eds.), pp. 362-409. Academic Press, New
York.
Loftus, J.C. and Albrecht, R.M. (1983). use of collodial
gold to examine fribrinogen binding to human platelets. Scanning Electron Microsc. 4, 1995-1999.
Machuga, E.J., Calton, G.J., and Burnett , J.W. (1986).
Purification of Bacillus anthracis lethal factor by
immunosorbent chromatography. Toxicon 24, 187-195.
Mekada, E., Ishiura, M., Kohne, K., Uchida, T., and Okada,
Y.
(1982). Association study of 125I-diphtheria
toxin with diphtheria toxin-resistant mutants isolated from chinese hamster ovary cells. ~ Toxins
35, 133-134.
Middlebrook, J.L., Dorland, R.B., and Leppla, S.H. (1978).
Association of diphtheria toxin with vera cells. J.
Biol. Chern. 253, 7325-7330.
Middlebrook, J.L. and Dorland, R.B. (1981).
Receptormediated internalization of diphtheria toxin.
In
Receptor Mediated Binding and Internalization of
Toxins and Hormones (J.L. Middlebrook and L.D. Kahn,
eds.), pp. 15-27.
Academic Press, New York.
Middlebrook, J.L. and Kahn, L.D. (1981). ReceptorMediated Binding and Internalization of Toxins and
Hormones, Academic-Fress, San Francisco.-----Middlebrook, J.L. and Dorland, R.B. (1984).
Bacterial
toxins: Cellular mechanisms of action.
Microbia l.
Rev . 48, 199-221.
Molnar, D.M. and Altenbern, R.A. (1963). Alterations in
the biological activity of protective antigen of
Bacillus anthracis toxin. Proc. Soc. Exp. Biol. Med.
114, 294-297.

85
Moolten, F.L., Schreiber, B.M., and Zajdel, S.H. (1982).
Antibodies conjugated to potent cytotoxins as specific
antitumor agents.
Immunological Rev.
62, 47-73.
Morris, N.P., Consiglio, E., Kohn, L.D., Habig, W.H.,
Hardegree, M.C., and Helting, T.B. (1980).
Interaction of fragments B and C of tetanus toxin with
neural and thyroid membranes of gangliosides. J.
Biol. Chern. 255, 6071-6076.
Moynihan, M.R. and Pappenheimer, A.M. Jr. (1981).
Kinetics of adenosinediphosphoribosylation of elongation factor 2 in cells exposed to diphtheria toxin.
Infect. Immun. 32, 575-582.
Nalin, D.R., Sultana, B., Sahunja, R., Islam, A.K.,
Rahim, M.A., Islam, M. Costa, B.S., Mawla, N., and
Greenough, W.B. (1977). Survival of a patient with
intestinal anthrax. ~ ~ Med.
62, 130-132.
Nicolson, G.L., Smith, J.R., and Hyman, R. (1978).
Dynamics of toxin and lectin receptors on a lymphoma
cell line and its toxin-resistant variant using
ferritin-conjugated 125 !-labelled ligand. ~ Cell
Biol. 78, 565-576.
Nielsen, T.B., Totsuka, Y., Kempner, E.S., and Field, J.B.
(1984).
Structure of the thyrotropin receptor and
thyroid adenylate cyclase system as determined by
target analysis. Biochemistry 23, 6009-6016.
Noda, M., Kato, I., Matasuda, F., and Hirayama, T. (1981).
Mode of action of staphylococcal leukocidin:
Relationship between binding of 125r-labeled Sand F
components of leukocidin to rabbit polymorphonuclear
leukocytes and leukocidin activity.
Infect. Immun.
34, 362-367.
-----Noda, M, Kato, I., Hirayama, T., and Matsuda, F. (1982).
Mode of action of staphylococcal leukocidin:
Effects of
the S and F components on the activities of membraneassociated enzymes of rabbit polymorphonuclear leukocytes.
Infect. Immun. 35, 38-45.
O'Brien, J., Friedlander, A., Dreier, T., Ezzell, J., and
Leppla, S.H. (1985).
Effects of anthrax toxin components on human neutrophils. Infect. Immun. 47, 306310.
Olsnes, S.
(1981). Directing toxins to cancer cells.
Nature 290, 84.

86
Osborne, J.C. Jr., Moss, J., Fishman, P.H., and Nakaya, S.
(1982). Specificity in protein-membrane associations: The interaction of gangliosides with
Escherichia coli and heat-labile enterotoxin and
choleragen. -sTOphys. ~ 37, 168-169.
Ouchterlony, o. (1948).
In vitro method for testing the
toxin-producing capacit~diphtheria bacteria. ACTA
Pathol. Microbiol. Scand. 25, 186-191.
Pappenheimer, A.M. (1977).
Biochem. 46, 69-94.

Diphtheria toxin.

Annu. Rev.

Puziss, M. and Wright, G.C. (1954). Studies on immunity
in anthrax. IV. Factors influencing elabaoration of
the protective antigen of Bacillus anthracis in
chemically defined media. ~ Bacteriol. 68, 474-482.
Record, B.R. and Wallis, R.G. (1956). Physiochemical examination of polyglutamic acid from Bacillus anthracis
grown in vivo.
Biochem. ~ 63, 443-447.
Ristroph, J.D. and Ivins, B.E. (1983). Elaboration of
BaCillus anthracis antigens in a new, defined culture
medium.
Infect. Immun. 39, 483-486.
Rogers, T.B. and Snyder, S.H. (1981). High affinity binding of tetanus toxin to mammalian brain membranes.
~ Biol. Chern. 256, 2402-2407.
Roth, R.A. and Maddux, B. (1983).
Insulin-cholera toxin
binding unit conjugate: A hybrid molecule with
insulin biological activity and cholera toxin binding
specificity. ~Cell. Physiol. 115, 151-158.
Sandvig, K., Olsnes, s., and Pihl, A. (1976). Kinetics of
binding of the toxic lectins abarin and ricin to
surface receptors of human cells. ~ Biol. Chern.
251, 3977-3984.
Scatchard, G. (1949). The attraction of proteins for small
molecules and ions. Ann. N.Y. Acad. Sci. 51, 660672.
Sheeler, P. and Bianchi, D.E. (1983). Cell Biology Structure, Biochemistry, and Function, John Wiley and Sons,
Inc., New York.
Simpson, L.L.

(1984). Botulinum toxin and tetanus toxin
similar membrane determinants. Brain Res.
305' 177-180.

recogn~ze

87
Sirisanthana, T., Navachareon, N., Tharavichtkul, P.,
Sjrisanthana, v ., and Brown, A.E. (1984). Outbreak
of oralorophalyngeal anthrax: An unusual manifestation of human infection with Bacillus anthracis. Am.
~ Trop. Med. Hyg. 33, 144-150.
-Smith, H. and Keppie, J. (1954). Observations on experimental anthrax: Demonstration of a specific lethal
factor produced in vivo by Bacillus anthracis.
Nature 173, 869-~0-.-Smith, H.
(1958). Symposium on recent developments in
immunization against bacterial disease: The basis of
immunity to anthrax. Proc. R. Soc. Med. 51, 375377.
------Smith, H.
and Stanley, J.L. (1962). Purification of the
third factor of anthrax toxin.
J. Gen. Microbial.
--29, 517-521.
Smith, H. and Stoner, H.B. (1967). Anthrax toxic component. Fed. Proc. 26, 1554-1557.
Solotorovsky, M. and Johnson, w. (1970). Tissue culture
and bacterial protein toxins.
In Microbial Toxins.
(S.J. Ajl, S. Kadis, and T.C. Montie,
eds.) , Vol. I.
pp. 277-324. Academic Press, New York.
Stanley, J.L. and Smith, H. (1961)
Purification of factor I and recognitition of a third factor of the
anthrax toxin. ~Gen. Microbial. 26, 49-66.
Stanley, J.L. and Smith, H. (1963). The three factors of
anthrax toxin: Their immunogenicity and lack of
demonstrable enzymatic activity. J. Gen. Microbial.
31, 329-337.
Stein, M.N. and Hoak, J.C. (1981). Thrombin receptors on
human endothelial cells: A morphologic study.
J.
Ultrastruc. Res. 74, 156-164.
Stephen, J. and Pietrowski, R.A. (1983). Bacterial
Toxins. American Society for Microbiology,
Washington D.C.
Tahernia, A.C. and Hashemi, G. (1972). Survival in
anthrax meningitis. Pediatrics 50, 329-332 .
Thorne, C.B ., Molnar, D.M., and Strange , R.E. ( 1960)
Production of toxin in vitro by Bacillus anthracis
and its separation into two components. J .
Bacterial. 79, 450-455.
0

88
Tsuji, T., Honda, T., Miwatani, T., Wakabayashi, S., and
Matsubara, H. (1985). Analysis of receptor-binding
site in Escherichia coli enterotoxin. J. Biol. Chern.
260, 8552-8558.
----- ----- ----Van Heyningen, W.E. (1970). General characteristics.
In
Microbial Toxins (S.J. Ajl, S. Kadis, and T.C. Montie,
eds.), vo1-.--I-.--pp. 1-26. Academic Press, New York.
Van Heyningen, S.
(1983). The interaction of cholera
toxin with gangliosides and ce ll membranes.
In
Current Topics in Membranes and Transport (A.
Kleinzeller, ed~, Vol. 18. -pp. 445-466. Academic
Press, New York.
Vodkin, M.H. and Leppla, S.H.
(1983). Cloning of the
protective antigen gene of Bacillus anthracis. Cell
34, 693-697.
Wade, B.H., Wright, G.C., Hewlett, E.L., Leppla, S.H., and
Mandell, G.L.
(1985). Anthrax toxin components
stimulate chemotaxis of human polymorphonuclear
neutrophils. Proc. Soc. ~ Biol. Med. 179, 159-162.
Westphal, U.
(1971). Steroid-Protein Interactions,
Springer-Verlag Press, New York.
Wilkie, M.H. and Ward, M.K. (1967). Characterization of
anthrax toxin. Fed. Proc. 26, 1527-1531.
Wilson, J .B. and Russell, K.E. (1964).
Isolation of
Bacillus anthracis from soil stored 60 years. J.
Bacterial. 87, 237-238.
Woodin, A.M.
(1970). Staphylococcal leukocidin.
In
Microbial Toxins.
(T.C. Montie, S. Kadis, and
S.J . Ajl, eds.), Vol. III. pp. 327-354. Academic
Press, New York.
Wright, G.G., Hedberg, M.A., and Slein, J.B. (1954).
Studies on immunity in anthrax: III. Elaboration of
protective antigen in a chemica lly-defined, nonprotein medium. ~ Immunol. 72, 263-269.
Yavin, E. and Nathan, A.
(1986). Tetanus toxin receptors
on nerve cells contain a trypsin -sentitive component.
Eur. ~ Biochem. 154, 403-407.
Zalman, L.S. and Wisnieski, B.J. (1984). Mechanism of
insertion of diphtheria toxin: Peptide entry and pore
size determinations .
Proc. Natl. Acad. Sci. USA. 81,
3341 -3345.
- - ----- - - - - - - -

89

Zwartouw, H.T. and Smith, H. (1956). Polyglutamic acid
from Bacillus anthracis grown in vivo: Structure and
aggressin activity. Biochem . J~6~37-453.

90

VITA
Name :

Dan iel Da lton Ma rt in

Persona l Data:

Born at Portland, Oregon, 25 September 1949
to Dalton w. a nd Stella L. Martin.
Ma rried 6 April 1982 to Cherie Anne Fischer

High School:

Lemoore Union High School
Lemoore, California

Co lleges:

Coali nga Junior Coll ege
Coalinga, California
California Poly t e chnic State Univ ersi t y
Sa n Luis Obis p o , California
Utah State University
Logan , Utah

De grees:

A.A., Coali nga Junior Coll ege (1 96 9)
Coalinga, Calif o rnia
B.S. in Bio logy, Cali forn ia Polytechnic
State Univ e rsity (1974)
San Luis Obispo, California
M.S. in Biology , Utah State University
(1983)
Logan, Utah

Profe ssional
Exper ience:

Microbiologist, Dugway Proving Ground
Half of ti me during cooperative education
program with Utah State University
Dugwa y, Utah (1979-1986)
Assistant Instructor, Utah State University
Logan, Utah (1 98 4)
Research Assistant for virology lab media
preparation, Utah State University
Logan, Utah (intermittently 1980-1985)
Resea rch presentation at national ASM
mee ting (Ma rch 1984)

Hobbies:

Woodworking, beekeeping, cross-country
skiing, guitar/singing

